{
    "testId": 396302261,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 106,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 21,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 2,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 2025,
    "averageTimeSpentInSeconds": 129,
    "otherAverageTimeSpentInSeconds": 62,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 18449,
            "questionIndex": 19917,
            "questionText": "<p>A 28-year-old woman comes to the office after a positive home pregnancy test.&nbsp; The patient is at 5 weeks gestation by a sure, regular last menstrual period.&nbsp; She has had some breast tenderness but no dysuria, vaginal bleeding, or cramping.&nbsp; The patient has no chronic medical conditions or prior surgeries.&nbsp; This is her first pregnancy, and she has no history of sexually transmitted infections.&nbsp; Vital signs and physical examination are unremarkable.&nbsp; Transvaginal ultrasound shows a slightly thickened endometrial stripe but no intrauterine gestation or adnexal masses.&nbsp; Quantitative &#946;-hCG is 1,100 mIU/mL and a repeat 48 hours later is 1,370 mIU/mL.&nbsp; The patient undergoes a diagnostic uterine dilation and curettage, and the next day &#946;-hCG level is 1,566 mIU/mL.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has a pregnancy of unknown location (ie, no visible intrauterine or extrauterine gestation on ultrasound), which may indicate an <a href=\"4710\">ectopic pregnancy</a> or an early intrauterine pregnancy (viable or nonviable).&nbsp; Because over 99% of viable intrauterine pregnancies have a &#8805;35% rise in &#946;-hCG levels over 48 hours, this patient&#39;s pregnancy (with &#946;-hCG rise of only 25%) is likely an ectopic or an abnormal, nonviable intrauterine pregnancy (eg, anembryonic gestation).</p><p>To distinguish between an ectopic pregnancy and nonviable intrauterine pregnancy, patients may undergo <strong>diagnostic dilation and curettage</strong>, a procedure that samples tissue within the endometrial cavity.&nbsp; The procedure confirms the abnormal pregnancy&#39;s location based on the <strong>postprocedure &#946;-hCG level</strong>:</p><ul><li><p>A negative or decreased &#946;-hCG level confirms that the patient had a nonviable intrauterine pregnancy; these patients require reassurance and observation only because the products of conception have been removed by the dilation and curettage <strong>(Choice D)</strong>.</p></li><li><p>In contrast, a <strong>persistent rise in &#946;-hCG level</strong> after dilation and curettage is diagnostic for an <strong>ectopic pregnancy</strong> (ie, the uterus has been evacuated but an extrauterine pregnancy continues to produce &#946;-hCG).&nbsp; These patients require additional management.</p></li></ul><p><strong>Methotrexate</strong> is the medical therapy for ectopic pregnancies in patients with hemodynamic stability; no renal, hepatic, or hematologic disorders (due to drug toxicity); and low &#946;-hCG level (ie, &lt;5000 mIU/mL).&nbsp; Methotrexate is a <strong>folate antagonist</strong> that inhibits DNA synthesis and cell growth preferentially in rapidly dividing cells (eg, trophoblasts).&nbsp; After treatment, patients require monitoring of &#946;-hCG levels until they become undetectable to ensure that treatment is complete.</p><p><strong>(Choice A)</strong>&nbsp; Levonorgestrel (ie, Plan B) can be used for emergency contraception in nonpregnant women by inhibiting ovulation.&nbsp; It is not used for ectopic pregnancy management.</p><p><strong>(Choice C)</strong>&nbsp; Mifepristone (progesterone antagonist) and misoprostol (prostaglandin E1 agonist) cause uterine contractions and are used for the medical management of spontaneous abortions; they are not used to treat ectopic pregnancy.</p><p><strong>(Choice E)</strong>&nbsp; Higher serum progesterone levels are usually associated with normal, viable intrauterine pregnancies (and lower levels with ectopic or nonviable intrauterine pregnancies).&nbsp; However, levels are not diagnostic for ectopic pregnancy due to low sensitivity and specificity; therefore, measurement is not indicated.</p><p><strong>Educational objective:</strong><br>Ectopic pregnancy (ie, pregnancy implanted in an extrauterine location) can be diagnosed by a persistent rise in &#946;-hCG level following diagnostic dilation and curettage.&nbsp; Medical therapy is with methotrexate, a folate antagonist that inhibits DNA synthesis in rapidly dividing cells (eg, trophoblasts).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4099,
            "topic": "Ectopic pregnancy",
            "titleId": 4099,
            "title": "Ectopic pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Levonorgestrel",
                    "choiceNumber": 1,
                    "correctTaken": 237,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methotrexate",
                    "choiceNumber": 2,
                    "correctTaken": 10907,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mifepristone and misoprostol",
                    "choiceNumber": 3,
                    "correctTaken": 2180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation only",
                    "choiceNumber": 4,
                    "correctTaken": 2739,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum progesterone levels",
                    "choiceNumber": 5,
                    "correctTaken": 639,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 123,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16702,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 120,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 11094,
            "questionIndex": 12236,
            "questionText": "<p>A 37-year-old woman, gravida 2 para 1, comes to the office to establish prenatal care.&nbsp; Her last menstrual period was 10 weeks ago.&nbsp; The patient has had some brown vaginal discharge and pelvic pressure over the past several days, but no frank blood or abdominal pain.&nbsp; She also reports mild nausea but no vomiting.&nbsp; The patient was undergoing infertility treatment and had several failed in vitro fertilization cycles before this spontaneous pregnancy.&nbsp; She takes a daily prenatal vitamin and does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 92/min.&nbsp; Speculum examination shows thick brown discharge in the vaginal vault, but no active bleeding.&nbsp; A 12-week-size uterus and bilateral adnexal masses are palpated on bimanual examination.&nbsp; Bedside pelvic ultrasound reveals bilaterally enlarged ovaries and an enlarged uterus filled with a heterogeneous mass composed of cystic structures.&nbsp; A urine pregnancy test is positive.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31152\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hydatidiform mole </strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Abnormal vaginal bleeding &plusmn;&nbsp;hydropic tissue</li><li>Uterine enlargement &gt; gestational age</li><li>Abnormally elevated &beta;-hCG levels</li><li>Theca lutein ovarian cysts</li><li>Hyperemesis gravidarum</li><li>Preeclampsia with severe features &nbsp;</li><li>Hyperthyroidism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Extremes of maternal age</li><li>History of hydatidiform mole</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>&quot;Snowstorm&quot; appearance on ultrasonography</li><li>Quantitative serum &beta;-hCG</li><li>Histologic evaluation of uterine contents</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>Dilation &amp; suction curettage</li><li>Serial serum &beta;-hCG post evacuation</li><li>Contraception for 6 months</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation of pelvic pressure, uterine size larger than expected for gestational age, and bilateral adnexal masses is concerning for a <strong>hydatidiform mole</strong>.&nbsp; Ultrasound findings of a hydatidiform mole include an enlarged uterus filled with a <strong>heterogeneous mass of cystic structures</strong>, often referred to as a &#x22;Swiss cheese&#x22; or <a href=\"3116\">&#x22;snowstorm&#x22; pattern</a>.&nbsp; <strong>Ovarian theca lutein cysts</strong>, as seen in this patient, are common with hydatidiform mole and develop due to ovarian hyperstimulation from markedly elevated &#946;-hCG levels.&nbsp; Risk factors for hydatidiform mole include infertility and extremes of maternal age (&#8804;15 and &gt;35).</p><p>Gestational trophoblastic neoplasia (GTN) can arise from a hydatidiform mole, and uterine evacuation via <strong>suction curettage</strong> is indicated to remove all of the premalignant tissue.&nbsp; Hysterectomy is an alternate management option for patients who have completed childbearing.&nbsp; After uterine evacuation (or hysterectomy), patients are followed with serial &#946;-hCG levels <strong>(Choice C)</strong>.&nbsp; Decreasing &#946;-hCG levels indicate resolution of the hydatidiform mole; plateauing or increasing levels indicate the development of GTN.</p><p><strong>(Choice A)</strong>&nbsp; Misoprostol is contraindicated in the management of hydatidiform mole due to the high risk of incomplete uterine evacuation.</p><p><strong>(Choice B)</strong>&nbsp; Laparoscopy is indicated for large and/or symptomatic ovarian cysts.&nbsp; This patient has no symptoms, and the theca lutein cysts will resolve after treatment of the hydatidiform mole when the &#946;-hCG level decreases.</p><p><strong>(Choice D)</strong>&nbsp; CA-125 is a tumor marker for epithelial ovarian carcinoma and is used to monitor disease progression.&nbsp; Ovarian theca lutein cysts do not express CA-125.</p><p><strong>(Choice E)</strong>&nbsp; Because hydatidiform mole is a premalignant condition, conservative management via repeat ultrasound in 1 week is contraindicated due to increased risk for persistent GTN and/or complications of hydatidiform mole (eg, hyperemesis gravidarum, preeclampsia).</p><p><strong>Educational objective:</strong><br>A complete hydatidiform mole can present with pelvic pressure, uterine size larger than expected for gestational age, and an ultrasound showing bilateral theca lutein ovarian cysts and an enlarged uterus with a heterogeneous mass composed of cystic spaces.&nbsp; Management includes uterine evacuation with suction curettage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administration of misoprostol",
                    "choiceNumber": 1,
                    "correctTaken": 1302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and serial &#946;-hCG levels",
                    "choiceNumber": 3,
                    "correctTaken": 2666,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtaining a CA-125 level",
                    "choiceNumber": 4,
                    "correctTaken": 332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat ultrasound in 1 week",
                    "choiceNumber": 5,
                    "correctTaken": 165,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suction curettage",
                    "choiceNumber": 6,
                    "correctTaken": 11593,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26556906",
                    "mediaDataId": 0,
                    "title": "Gestational trophoblastic disorders: an update in 2015.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26556906",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 151,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16800,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 151,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 13870,
            "questionIndex": 15264,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office for a routine prenatal visit.&nbsp; Three weeks ago, she developed a facial rash that has darkened despite the use of over-the-counter lotions.&nbsp; For the past month, the patient has had increasing fatigue and dizziness at her work at a landscape company, but these symptoms improved with increased snacking and hydration.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; The patient has no chronic medical conditions and takes a daily prenatal vitamin and iron supplement.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/70 mm Hg, and pulse is 72/min.&nbsp; Fetal heart rate is 145/min.&nbsp; Dark, irregularly shaped macules are arranged in a bilaterally symmetric fashion on the patient&#39;s cheeks and nasal bridge.&nbsp; The macules do not affect the nasolabial fold.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp; Hemoglobin</td><td style=\"vertical-align:middle;\">12.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp; Platelets</td><td style=\"vertical-align:middle;\">180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp; Protein</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp; Blood</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp; Glucose</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Which of the following is the most appropriate next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"48017\" src=\"https://www.uworld.com/media/highresdefault/L14636.png\"  ></p>&nbsp;<p>This patient has <strong>melasma</strong>, an acquired hyperpigmentation disorder that occurs on <strong>sun-exposed areas of the face</strong>.&nbsp; Melasma likely occurs when ultraviolet radiation triggers melanocyte proliferation and pigment deposition.&nbsp; It is more common in women of reproductive age, particularly during <strong>pregnancy</strong> because estrogen and progesterone also stimulate melanocyte proliferation.&nbsp; Additional risk factors include darker skin tones, thyroid dysfunction, medications (eg, antiepileptics), and cosmetic use.</p><p>Patients typically develop <strong>irregularly shaped</strong>, <strong>hyperpigmented macules</strong> of varying color (eg, light to dark brown, ash/blue) that occur in a symmetric centrofacial, mandibular, or <strong>malar distribution</strong>.&nbsp; Melasma is not associated with systemic symptoms; this patient&#39;s fatigue and dizziness are most consistent with normal third-trimester physiology (ie, slow venous return due to the enlarging gravid uterus) because her symptoms resolve with snacking and hydration.</p><p>Melasma is diagnosed clinically and <strong>requires no further evaluation</strong>.&nbsp; Management during pregnancy includes minimizing progression of the hyperpigmentation with sun exposure avoidance and broad-spectrum sunscreen use.&nbsp; Melasma typically resolves postpartum; areas that do not resolve can be treated with skin-lightening agents or topical retinoids after delivery.</p><p><strong>(Choice A)</strong>&nbsp; Antinuclear antibody testing can be used to evaluate for systemic lupus erythematosus, which commonly presents with a classic <a href=\"44498\">malar rash</a> with nasolabial fold sparing; however, the rash typically is erythematous.&nbsp; Additional clinical features may include hypertension, anemia, thrombocytopenia, and proteinuria.</p><p><strong>(Choice C)</strong>&nbsp; Serum bile acid levels are used to evaluate for intrahepatic cholestasis of pregnancy, which may present in the third trimester with generalized pruritus (worse on the hands and feet).&nbsp; However, patients do not develop a rash or hyperpigmentation.</p><p><strong>(Choice D)</strong>&nbsp; A serum cortisol level is used to evaluate for adrenal insufficiency, which can present with hyperpigmentation and fatigue; however, the hyperpigmentation is typically generalized rather than focal, and the associated fatigue is usually not improved with food and hydration.</p><p><strong>(Choice E)</strong>&nbsp; Serum iron studies are used to evaluate for iron deficiency anemia, which can present with fatigue and dizziness but is unlikely in this patient with a normal hemoglobin level.&nbsp; Iron studies can also evaluate for hereditary hemochromatosis, which may cause hyperpigmentation or bronze discoloration; however, the hyperpigmentation is not limited to the face, as in this patient.</p><p><strong>Educational objective:</strong><br>Melasma, an acquired hyperpigmentation disorder that commonly occurs during pregnancy, typically presents with bilateral, symmetric macules on sun-exposed areas of the face.&nbsp; Melasma is clinically diagnosed and typically resolves postpartum.&nbsp; It is managed with avoidance of sun exposure and use of broad-spectrum sunscreen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 24239,
            "topic": "Dermatoses of pregnancy",
            "titleId": 24239,
            "title": "Dermatoses of pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody test",
                    "choiceNumber": 1,
                    "correctTaken": 4384,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No further evaluation indicated",
                    "choiceNumber": 2,
                    "correctTaken": 10026,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum bile acid levels",
                    "choiceNumber": 3,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum cortisol level",
                    "choiceNumber": 4,
                    "correctTaken": 1023,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum iron studies",
                    "choiceNumber": 5,
                    "correctTaken": 277,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25184917",
                    "mediaDataId": 0,
                    "title": "Melasma: a clinical and epidemiological review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25184917",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 296,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 15844,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 296,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 11169,
            "questionIndex": 12319,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 23 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> emergency department</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> &#x22;I started having vaginal bleeding after intercourse.&#x22;<br><strong>History of Present Illness:</strong><br>&#8226; had intercourse 12 hours ago<br>&#8226; later noticed blood in the toilet after urination and bright red blood on the toilet paper<br><strong>Past Medical History:</strong><br>&#8226; no chronic medical conditions<br><strong>Obstetric and Gynecologic History:</strong><br>&#8226; gravida 1 para 0 at 12 weeks gestation<br><strong>Medications:</strong><br>&#8226; prenatal vitamin<br><strong>Allergies:</strong><br>&#8226; no known drug allergies<br><strong>Family History:</strong><br>&#8226; noncontributory<br><strong>Psychosocial History:</strong><br>&#8226; occasional alcohol use prior to pregnancy<br>&#8226; no tobacco or recreational drug use</p><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"text-align:center;\"><tbody><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O<font size=\"2\"><sub>2</sub></font> Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr><td>37 C<br>(98.6 F)</td><td style=\"vertical-align:top;\">65/min</td><td style=\"vertical-align:top;\">16/min</td><td>120/70<br>mm Hg</td><td>99%<br>on RA</td><td style=\"vertical-align:top;\">&ndash;</td><td style=\"vertical-align:top;\">&ndash;</td><td style=\"vertical-align:top;\">22 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><p>&#8226; Appearance: alert and oriented<br>&#8226; Pulmonary: clear to auscultation<br>&#8226; Cardiac: regular rate and rhythm<br>&#8226; Abdominal: soft, nontender, nondistended<br>&#8226; Pelvic: normal external genitalia; thick, yellow, malodorous, blood-tinged discharge in the vagina; cervix is closed and bleeds after being touched with a cotton swab; no masses; on bimanual examination, uterus is enlarged but there is no cervical motion tenderness, adnexal mass, or tenderness</p><p><u><strong>Diagnostic Studies</strong></u><br>&#8226; Fetal Doppler ultrasonography: normal fetal heart rate</p><p><u><strong>Question:</strong></u> Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2064\" src=\"https://www.uworld.com/media/highresdefault/L22227.jpg\"  ></p><p>This pregnant patient with <strong>postcoital bleeding</strong> and thick, mucopurulent discharge most likely has <strong>acute cervicitis</strong> caused by infection with <em>Chlamydia trachomatis</em> or <em>Neisseria gonorrhoeae</em>, the 2 most prevalent sexually transmitted bacteria in women age &lt;25.&nbsp; Other less common symptoms of cervicitis include dysuria, dyspareunia, and vulvovaginal pruritus.&nbsp; <strong>Pregnant patients</strong> with cervicitis often have <strong>no cervical motion tenderness</strong> (a sign of ascending upper reproductive tract infection) because the gravid uterus is sealed from the lower reproductive tract to maintain uterine sterility via the mucus plug.</p><p>Acute cervicitis is diagnosed clinically by the presence of a <strong>malodorous, mucopurulent discharge</strong> and a <strong>friable cervix</strong> (eg, bleeds easily on contact) on pelvic examination.&nbsp; Nucleic acid amplification testing should be performed for confirmation.&nbsp; However, <strong>empiric treatment</strong> is recommended because a delay increases the risk for obstetric complications (eg, spontaneous abortion, preterm prelabor rupture of membranes).&nbsp; Pregnant patients are treated empirically with ceftriaxone and azithromycin; doxycycline is avoided due to potential teratogenic effects.</p><p><strong>(Choice B)</strong>&nbsp; Bacterial vaginosis, caused by overgrowth of <em>Gardnerella vaginalis</em>, is an uncommon cause of acute cervicitis.&nbsp; Patients typically have thin, gray discharge with a fishy odor rather than mucopurulent discharge and cervical bleeding.</p><p><strong>(Choice C)</strong>&nbsp; A <a href=\"5957\">cervical polyp</a> can cause intermenstrual spotting or postcoital bleeding.&nbsp; However, cervical polyps are typically visible on pelvic examination, appearing as red, lobular structures originating from the cervix.</p><p><strong>(Choice D)</strong>&nbsp; An inevitable abortion presents with vaginal bleeding, cramping, and a dilated cervix, often with products of conception visualized at the os.&nbsp; This patient has a closed cervix and no pain, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; In contrast to this patient with bleeding from the cervix due to acute cervicitis, patients with threatened abortion typically have bleeding originating in the uterus (eg, bleeding from the endocervical canal on examination).</p><p><strong>Educational objective:</strong><br>Acute cervicitis can cause postcoital bleeding, mucopurulent discharge, and a friable cervix.&nbsp; In pregnancy, acute cervicitis is treated empirically with ceftriaxone and azithromycin to cover the most common pathogens, <em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em>.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute cervicitis",
                    "choiceNumber": 1,
                    "correctTaken": 6359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial vaginosis",
                    "choiceNumber": 2,
                    "correctTaken": 1263,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical polyp",
                    "choiceNumber": 3,
                    "correctTaken": 460,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inevitable abortion",
                    "choiceNumber": 4,
                    "correctTaken": 94,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Threatened abortion",
                    "choiceNumber": 5,
                    "correctTaken": 1121,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33332296",
                    "mediaDataId": 0,
                    "title": "Update to CDC&#39;s treatment guidelines for gonococcal infection, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33332296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25045355",
                    "mediaDataId": 0,
                    "title": "Postcoital bleeding: a review on etiology, diagnosis, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25045355",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 9297,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 98,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 10971,
            "questionIndex": 12109,
            "questionText": "<p>A 25-year-old woman, gravida 1 para 1, comes to the office due to malodorous vaginal discharge for the past 2 weeks.&nbsp; She tried over-the-counter topical vaginal cleansers with no improvement of her symptoms.&nbsp; Four weeks ago, the patient had a forceps-assisted vaginal delivery complicated by a third-degree laceration, which was repaired with absorbable suture.&nbsp; After delivery, vaginal packing was placed for 24 hours to tamponade the traumatized vaginal tissue.&nbsp; Her lochia stopped a week ago, and she has had no additional bleeding.&nbsp; Vitals signs are normal.&nbsp; On pelvic examination, the perineum is intact, and there is a small, dark red, velvety area on the posterior vaginal wall with an associated malodorous, tan-brown discharge.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34875\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Rectovaginal fistula</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Pelvic radiation</li><li>Obstetric trauma</li><li>Pelvic surgery</li><li>Colon cancer</li><li>Diverticulitis</li><li>Crohn disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Uncontrollable passage of gas &amp;/or feces from the vagina</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic studies</strong></p></td><td><ul><li>Physical examination</li><li>Fistulography</li><li>MRI</li><li>Endosonography</li></ul></td></tr></tbody></table></div><p>This patient with malodorous, tan-brown vaginal discharge and a posterior vaginal lesion likely has a <strong>rectovaginal fistula (RVF)</strong>, an <a href=\"25646\">aberrant connection</a> between the rectum and vagina.&nbsp; RVFs most often occur after <strong>third- or fourth-degree</strong> <a href=\"24036\">perineal lacerations</a> with inadequate wound repair or wound infection and breakdown.</p><p>A large perineal laceration, as in this patient, can cause abnormal healing of the rectovaginal septum.&nbsp; Because of the proximity of the rectum to the vagina, rectal mucosa may infiltrate and form a fistulous tract during healing, resulting in rectal mucosa being visible on the <strong>posterior vaginal wall</strong>, often appearing as a <strong>dark red, velvety lesion</strong>.&nbsp; As the fistula gradually develops (over weeks to months) and expands, flatus and fecal material pass through the vagina, resulting in a <strong>malodorous, tan-brown discharge</strong>.</p><p>Diagnosis is typically clinical and based on visualization of a posterior vaginal defect; for patients with an unclear presentation, imaging may be performed.&nbsp; Treatment is with surgical repair.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"10666\">Bartholin gland abscesses</a> can present with malodorous discharge due to purulence; however, affected patients have an associated painful, indurated posterior vulvar mass located at the 4- or 8-o&#39;clock position.</p><p><strong>(Choice C)</strong>&nbsp; A retained foreign body (eg, gauze) can cause malodorous vaginal discharge but is typically seen on examination because it obstructs visualization of normal pelvic structures (eg, posterior vaginal wall).</p><p><strong>(Choices D and F)</strong>&nbsp; Symptomatic <a href=\"20426\"><em>Trichomonas</em> vaginitis</a> causes yellow-green, frothy, malodorous vaginal discharge.&nbsp; <a href=\"19613\">Vulvovaginal candidiasis</a> can cause thick, white vaginal discharge.&nbsp; However, both conditions typically have generalized vulvovaginal inflammation with erythema rather than a discrete, velvety lesion.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"4908\">Vesicovaginal fistulas</a> present with clear, watery vaginal discharge (ie, urine) and a fistulous tract on the anterior, rather than the posterior, vaginal wall.</p><p><strong>Educational objective:</strong><br>Rectovaginal fistulas may occur after obstetric trauma (eg, third- or fourth-degree perineal lacerations), and patients typically have incontinence of flatus and feces (eg, a malodorous, tan-brown discharge) through the vagina.&nbsp; Dark red, velvety rectal mucosa may be seen on the posterior vaginal wall.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23657,
            "topic": "Rectovaginal fistula",
            "titleId": 23657,
            "title": "Rectovaginal fistula",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 1,
                    "correctTaken": 246,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rectovaginal fistula",
                    "choiceNumber": 2,
                    "correctTaken": 11903,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retained vaginal gauze",
                    "choiceNumber": 3,
                    "correctTaken": 3961,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trichomoniasis",
                    "choiceNumber": 4,
                    "correctTaken": 156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vesicovaginal fistula",
                    "choiceNumber": 5,
                    "correctTaken": 346,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvovaginal candidiasis",
                    "choiceNumber": 6,
                    "correctTaken": 74,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26929752",
                    "mediaDataId": 0,
                    "title": "Rectovaginal fistulae.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26929752",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26476822",
                    "mediaDataId": 0,
                    "title": "Presentation and management of rectovaginal fistulas after delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26476822",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16686,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 108,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 4245,
            "questionIndex": 4245,
            "questionText": "<p>A 38-year-old woman comes to the office for evaluation of fatigue and amenorrhea.&nbsp; The patient says she has been exhausted for the past 5 months since the birth of her twins.&nbsp; She has had difficulty keeping up with her new responsibilities and has not had an appetite.&nbsp; She feels disappointed that she was unable to breastfeed after multiple visits with a lactation consultant.&nbsp; The patient had a vaginal delivery complicated by a retained placenta, which required dilation and curettage and multiple blood transfusions.&nbsp; She also has major depressive disorder treated with an antidepressant that she discontinued when she learned she was pregnant.&nbsp; Her last menstrual period was before the pregnancy.&nbsp; Weight is 52 kg (115 lb), which is the same as her prepregnancy weight.&nbsp; BMI is 19 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 80/50 mm Hg and pulse is 65/min.&nbsp; On physical examination, the patient appears thin and tired.&nbsp; Hemoglobin is 10.1 g/dL.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T103383\" style=\"overflow-x:auto;\"><table class=\"table-default-style\" style=\"width:540px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Sheehan syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Obstetric hemorrhage complicated by hypotension</li><li>Postpartum anterior pituitary infarction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Spectrum of disease based on severity of pituitary infarction (immediate adrenal crisis &#8594; years after delivery)</li><li>Lactation failure (&#8595; prolactin)</li><li>Amenorrhea, hot flashes, vaginal atrophy (&#8595; FSH, LH)</li><li>Fatigue, bradycardia (&#8595; TSH)</li><li>Anorexia, weight loss, hypotension (&#8595; ACTH)</li><li>&#8595; Lean body mass (&#8595; GH)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Cortisol level (most important)</li><li>Thyroxine level</li><li>FSH level</li><li>Prolactin level</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Corticosteroids</li><li>Estrogen-progestin replacement therapy</li></ul></td></tr></tbody></table></div><p>This patient&#39;s postpartum hemorrhage with subsequent lactation failure, hypotension, and fatigue is concerning for <strong>Sheehan syndrome (pituitary infarction)</strong>.&nbsp; During pregnancy, the pituitary gland enlarges because high estrogen levels induce lactotroph hyperplasia.&nbsp; However, because blood supply does not increase proportionally, the anterior pituitary becomes vulnerable to ischemia from hemorrhagic shock.&nbsp; Therefore, the classic presentation of Sheehan syndrome occurs following <strong>massive postpartum hemorrhage</strong>.</p><p>The resultant pituitary ischemia causes <strong>panhypopituitarism</strong> and deficiency of the <a href=\"11541\">hormones of the anterior pituitary gland</a>, resulting in the following constellation of symptoms:</p><ul><li><p>Prolactin deficiency:&nbsp; <strong>lactation failure</strong></p></li><li><p>ACTH deficiency:&nbsp; <strong>fatigue, persistent hypotension</strong>, anorexia with weight loss (from ACTH and subsequent cortisol deficiency [ie, secondary adrenal insufficiency])</p></li><li><p>Gonadotropin (FSH, LH) deficiency:&nbsp; <strong>amenorrhea</strong></p></li><li><p>TSH deficiency:&nbsp; fatigue, bradycardia (ie, central hypothyroidism)</p></li></ul><p>Patients with suspected Sheehan syndrome require hormone levels (eg, cortisol, FSH, prolactin) to confirm the deficiencies and guide management for hormone replacement.</p><p><strong>(Choice A)</strong>&nbsp; Bilateral adrenal gland <a href=\"4121\">infarction</a> (due to hemorrhage or thrombosis) presents with acute primary adrenal insufficiency (eg, hypotension and shock).&nbsp; Although this patient has fatigue and hypotension, her additional symptoms (eg, amenorrhea, lactation failure) are the result of additional hormone deficiencies, suggesting a more central (pituitary) cause.</p><p><strong>(Choice B)</strong>&nbsp; Damage to the endometrial basalis layer can occur with dilation and curettage, resulting in <a href=\"26490\">intrauterine adhesions</a> and subsequent amenorrhea.&nbsp; This condition, Asherman syndrome, is an anatomic (not hormonal) deficit, so it is not the cause of the patient&#39;s other symptoms (eg, hypotension, lactation failure).</p><p><strong>(Choice C)</strong>&nbsp; Folate, iron, and vitamin B<font size=\"2\"><sub>12</sub></font> deficiencies can cause anemia and fatigue.&nbsp; Amenorrhea and bradycardia (pulse &lt;60) may also occur if associated with severe malnutrition from anorexia nervosa (unlikely in this patient with a normal BMI).&nbsp; Although caloric and nutritional needs are greater in lactating women to maintain milk supply, malnutrition does not typically affect the quantity or quality of breast milk production.</p><p><strong>(Choice E)</strong>&nbsp; This patient&#39;s complicated delivery, stress, and history of depression could contribute to fatigue, weight loss, and breastfeeding difficulties.&nbsp; However, psychosocial impairment alone does not explain the hypotension and amenorrhea.</p><p><strong>(Choice F)</strong>&nbsp; Postpartum thyroiditis is an autoimmune-mediated inflammatory destruction of the thyroid gland that results in hyper- or hypothyroidism.&nbsp; Some signs of hypothyroidism (eg, bradycardia) can develop in patients with Sheehan syndrome (due to central hypothyroidism); however, thyroid disorder does not cause hypotension or lactation failure.</p><p><strong>Educational objective:</strong><br>Sheehan syndrome (pituitary infarction) is a complication of massive obstetric hemorrhage.&nbsp; The classic presentation includes lactation failure, persistent hypotension, and amenorrhea.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 2767,
            "topic": "Hypopituitarism",
            "titleId": 2767,
            "title": "Hypopituitarism",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal gland infarction",
                    "choiceNumber": 1,
                    "correctTaken": 170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial basalis damage",
                    "choiceNumber": 2,
                    "correctTaken": 38,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nutritional deficiency",
                    "choiceNumber": 3,
                    "correctTaken": 303,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary gland infarction",
                    "choiceNumber": 4,
                    "correctTaken": 4212,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychosocial impairment",
                    "choiceNumber": 5,
                    "correctTaken": 218,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid gland destruction",
                    "choiceNumber": 6,
                    "correctTaken": 129,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20944496",
                    "mediaDataId": 0,
                    "title": "The changing face of Sheehan&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20944496",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 273,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 5070,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 273,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 15068,
            "questionIndex": 16492,
            "questionText": "<p>A 34-year-old woman, gravida 2 para 1, at 14 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She is feeling well and has no concerns.&nbsp; The patient had daily nausea and vomiting for the first few weeks of her pregnancy, but these symptoms resolved 2 weeks ago.&nbsp; She has had no pelvic pain or vaginal bleeding.&nbsp; The patient has not yet felt fetal movement.&nbsp; Her first pregnancy ended in a cesarean delivery at 30 weeks gestation due to breech presentation and preeclampsia with severe features.&nbsp; The patient has no chronic medical conditions.&nbsp; Her only medication is a daily prenatal vitamin, and she has no medication allergies.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 112/74 mm Hg.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart tones are 155/min.&nbsp; The uterus is gravid and nontender.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32393\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preeclampsia prevention</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>New-onset hypertension &amp; proteinuria &amp;/or<br />end-organ damage at &gt;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>High risk </strong></p></td><td><ul><li>Prior preeclampsia</li><li>Chronic kidney disease</li><li>Chronic hypertension</li><li>Diabetes mellitus</li><li>Multiple gestation</li><li>Autoimmune disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Moderate risk</strong></p></td><td><ul><li>Obesity</li><li>Advanced maternal age</li><li>Nulliparity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Low-dose aspirin at 12 weeks gestation</li></ul></td></tr></tbody></table></div><p>Preeclampsia is a leading cause of maternal and fetal morbidity and mortality due to the increased risk of stroke, placental abruption, and disseminated intravascular coagulation.&nbsp; Preeclampsia likely results from abnormal vasoconstriction and increased platelet aggregation, resulting in placental infarction and ischemia.</p><p>Patients with predisposing factors, such as chronic kidney disease, chronic hypertension, and <strong>preeclampsia in a prior pregnancy</strong> (particularly with severe features or at &lt;37 weeks gestation, as in this patient), are at high risk for developing preeclampsia.</p><p>In <strong>high-risk patients</strong>, daily <strong>low-dose aspirin</strong> is the only therapy proven to <strong>decrease the risk of preeclampsia</strong> because it inhibits platelet aggregation and helps prevent placental ischemia.&nbsp; It is initiated at 12-28 weeks gestation (but optimally before 16 weeks), then continued daily until delivery.</p><p><strong>(Choice A)</strong>&nbsp; Betamethasone helps accelerate fetal lung maturity in patients at preterm gestation who are at imminent risk for preterm delivery.&nbsp; If this patient develops preeclampsia requiring preterm delivery, betamethasone would be indicated at that time.</p><p><strong>(Choice B)</strong>&nbsp; High-dose (4 mg) folic acid is indicated in patients at high risk for a fetus with neural tube defects (eg, prior affected pregnancy, use of folate antagonist medications).&nbsp; This patient is at average risk and requires the typical dose (0.4 mg) found in most prenatal vitamins.</p><p><strong>(Choice C)</strong>&nbsp; Intramuscular hydroxyprogesterone is offered to pregnant patients with a prior spontaneous preterm delivery as it may decrease the risk of recurrent preterm delivery.&nbsp; It is not indicated in patients, such as this one, who have undergone preterm delivery for medical indications (eg, preeclampsia with severe features, fetal growth restriction).</p><p><strong>(Choice E)</strong>&nbsp; Vaginal progesterone is recommended to decrease the risk of preterm delivery in patients with a shortened cervix (eg, &#8804;2.5 cm), which is usually identified incidentally on transvaginal ultrasound between 16 and 24 weeks gestation.&nbsp; This patient is at 14 weeks gestation.</p><p><strong>Educational objective:</strong><br>Patients at high risk for preeclampsia (eg, preeclampsia in prior pregnancy) are initiated on low-dose aspirin prophylaxis during pregnancy for preeclampsia prevention.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Betamethasone",
                    "choiceNumber": 1,
                    "correctTaken": 481,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-dose (4 mg) folic acid",
                    "choiceNumber": 2,
                    "correctTaken": 1956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular hydroxyprogesterone",
                    "choiceNumber": 3,
                    "correctTaken": 818,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose aspirin",
                    "choiceNumber": 4,
                    "correctTaken": 12799,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal progesterone",
                    "choiceNumber": 5,
                    "correctTaken": 682,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34581730",
                    "mediaDataId": 0,
                    "title": "Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34581730",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29939940",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 743: low-dose aspirin use during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29939940",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26926408",
                    "mediaDataId": 0,
                    "title": "Hypertensive disorders of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26926408",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 186,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16736,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 186,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 14073,
            "questionIndex": 15476,
            "questionText": "<p>A 34-year-old woman, gravida 4 para 2 aborta 1, comes to the emergency department at 24 weeks gestation with vaginal bleeding that started after intercourse.&nbsp; The patient woke up in a pool of bright red blood and continues to soak through a pad every hour.&nbsp; She has not had routine prenatal care during this pregnancy but had a sonogram at 8 weeks gestation that showed a singleton intrauterine pregnancy.&nbsp; The patient has had 2 cesarean deliveries at term and a cervical conization earlier this year.&nbsp; She smokes a pack of cigarettes daily but does not use alcohol or illicit drugs.&nbsp; Blood pressure is 124/78 mm Hg and pulse is 92/min.&nbsp; Fetal monitoring shows a baseline of 140/min, accelerations, absent decelerations, and moderate variability.&nbsp; Irregular contractions are seen on tocodynamometry.&nbsp; Abdominal examination reveals a gravid, nontender uterus.&nbsp; On speculum examination, there are large clots in the vaginal vault, a closed cervix, and active bleeding from the os.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33314\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Placenta previa </strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Prior placenta previa</li><li>Prior cesarean delivery</li><li>Multiple gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features </strong></p></td><td><ul><li>Painless vaginal bleeding at &gt;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Transabdominal followed by transvaginal sonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>No intercourse</li><li>No digital cervical examination</li><li>Inpatient admission for bleeding episodes</li></ul></td></tr></tbody></table></div><p>This patient&#39;s vaginal bleeding after 20 weeks gestation is due to <strong>placenta previa</strong>, a condition in which the <strong>placenta covers the cervix</strong>.&nbsp; This patient&#39;s risk factors for placenta previa include prior cesarean delivery, multiparity, and smoking; additional risk factors include prior placenta previa and multiple gestation.&nbsp; <a href=\"4184\">Placenta previa</a> has the potential for massive antepartum hemorrhage because cervical manipulation (even minimal manipulation from intercourse) causes partial placental detachment and <strong>painless vaginal bleeding</strong> (eg, nontender uterus, painless irregular contractions) from the intervillous space.&nbsp; This bleeding is primarily of maternal origin; therefore, many patients have <strong>reassuring fetal monitoring</strong> initially (eg, accelerations, no decelerations).</p><p>Treatment depends on maternal hemodynamic stability and fetal status.&nbsp; Stable patients are managed expectantly, as most previas resolve by the third trimester.&nbsp; Patients with persistent previa undergo cesarean delivery at 36-37 weeks gestation (prior to the onset of labor).</p><p><strong>(Choice A)</strong>&nbsp; Cervical insufficiency causes second trimester pregnancy loss due to intrinsic cervical instability or from a reduced cervical length (eg, prior cervical conization).&nbsp; Most patients have an incidental shortened or dilated cervix on ultrasound.&nbsp; There is typically no vaginal bleeding.&nbsp; Symptomatic patients typically have pelvic pressure and painless cervical dilation; this patient&#39;s cervix is closed.</p><p><strong>(Choice B)</strong>&nbsp; Complete hydatidiform mole usually causes first trimester vaginal bleeding.&nbsp; This diagnosis is unlikely because complete hydatidiform moles have a snowstorm appearance due to hydropic villi and an absent fetus on ultrasound.</p><p><strong>(Choice C)</strong>&nbsp; Inevitable abortion presents at &lt;20 weeks gestation with vaginal bleeding, pelvic pain, and a dilated cervix.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"1056\">Placental abruption</a>, the separation of the placenta from the uterus prior to fetal delivery, causes vaginal bleeding and uterine contractions.&nbsp; Abruptio placentae is more common in smokers (as in this patient), but patients typically have constant abdominal pain (ie, tender uterus) and fetal decelerations.</p><p><strong>(Choice F)</strong>&nbsp; Preterm labor is cervical dilation &#8805;3 cm or effacement (eg, length &lt;2 cm) with regular painful uterine contractions at &lt;37 weeks gestation.&nbsp; Light bleeding due to cervical vascularity may be seen; however, frank hemorrhage (as in this patient) is not consistent with labor.&nbsp; In addition, this patient&#39;s contractions are irregular and her cervix is closed.</p><p><strong>Educational objective:</strong><br>Placenta previa occurs when the placenta covers the cervix and presents with painless vaginal bleeding after 20 weeks gestation.&nbsp; Blood loss is primarily maternal; therefore, initial fetal monitoring is typically reassuring.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 2227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complete hydatidiform mole",
                    "choiceNumber": 2,
                    "correctTaken": 31,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inevitable abortion",
                    "choiceNumber": 3,
                    "correctTaken": 1707,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 4,
                    "correctTaken": 9825,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental abruption",
                    "choiceNumber": 5,
                    "correctTaken": 2371,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm labor",
                    "choiceNumber": 6,
                    "correctTaken": 472,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30128867",
                    "mediaDataId": 0,
                    "title": "Risk factors and pregnancy outcomes: complete versus incomplete placenta previa in mid-pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30128867",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30016336",
                    "mediaDataId": 0,
                    "title": "Effect of site of placentation on pregnancy outcomes in patients with placenta previa.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30016336",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16633,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 112,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 2485,
            "questionIndex": 2485,
            "questionText": "<p>A 5-hour-old girl is evaluated in the newborn nursery due to &#x22;crying a lot.&#x22;&nbsp; She was born at 40 weeks gestation by vacuum-assisted vaginal delivery to a mother with gestational diabetes mellitus.&nbsp; The delivery was complicated by a prolonged second stage of labor due to difficulty in delivering the shoulders.&nbsp; Estimated fetal weight on prenatal ultrasound was 4 kg (8.8 lb).&nbsp; The patient&#39;s birth weight was 4.6 kg (10 lb).&nbsp; Physical examination shows a small area of scalp edema that does not cross suture lines.&nbsp; Palpation of the left clavicular bone reveals crepitus.&nbsp; Passive movement of the left upper extremity elicits crying.&nbsp; Moro reflex is decreased on the left.&nbsp; Bilateral extremities are neurovascularly intact.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35288\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neonatal displaced clavicular fracture </strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Risk&nbsp;factors</strong></p></td><td style=\"width: 75%;\"><ul><li>Fetal macrosomia (maternal diabetes mellitus, postterm pregnancy)</li><li>Instrumental delivery (vacuum or forceps)</li><li>Shoulder dystocia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features</strong></p></td><td><ul><li>Crying/pain with passive motion of affected extremity</li><li>Crepitus over clavicle</li><li>Asymmetric Moro reflex</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>X-ray</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Reassurance</li><li>Gentle handling</li><li>Analgesics</li><li>Place affected arm in a long-sleeved garment &amp; pin sleeve to chest with elbow flexed at 90 degrees</li></ul></td></tr></tbody></table></div><p>This newborn with crepitus over the clavicle, asymmetric Moro reflex, and pain with passive motion of the upper extremity has a <strong>displaced clavicular fracture</strong>.&nbsp; Neonatal clavicular fractures are typically due to a difficult delivery.&nbsp; Risk factors include <strong>birth weight &gt;4 kg</strong> (often associated with maternal gestational diabetes mellitus), <strong>shoulder dystocia</strong>, and <strong>vacuum delivery</strong>.&nbsp; Vacuum extraction can also cause a subperiosteal bleed (ie, <a href=\"725\">cephalohematoma</a>), as seen in this patient.</p><p>X-rays are performed to confirm the <a href=\"670\">fracture</a>.&nbsp; Because neonatal clavicular fractures usually <strong>heal rapidly</strong> (7-10 days) with no long-term sequelae, management includes parental <strong>reassurance</strong> and guidance on <strong>gentle handling</strong>.&nbsp; To decrease pain, arm motion may be restricted by pinning the infant&#39;s sleeve to the shirt.</p><p><strong>(Choice A)</strong>&nbsp; Analgesics (eg, acetaminophen) can be given to decrease pain.&nbsp; However, aspirin is generally avoided in infants and children due to the risk of Reye syndrome.</p><p><strong>(Choice B)</strong>&nbsp; Closed reduction is appropriate treatment for shoulder dislocation, which rarely occurs in neonates and would not cause clavicular crepitus.</p><p><strong>(Choices C and D)</strong>&nbsp; Traumatic clavicular fractures in older children are less likely to heal spontaneously and may require treatment.&nbsp; Displaced fractures are often surgically reduced, and nondisplaced fractures are typically managed with a figure-of-8 splint.</p><p><strong>Educational objective:</strong><br>Birth weight &gt;4 kg, shoulder dystocia, and vacuum delivery are risk factors for neonatal clavicular fractures.&nbsp; Management includes reassurance and gentle handling, as most neonatal clavicular fractures heal rapidly without complications.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 483,
            "topic": "Clavicle fracture",
            "titleId": 483,
            "title": "Clavicle fracture",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer aspirin for analgesia",
                    "choiceNumber": 1,
                    "correctTaken": 113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Closed reduction using traction",
                    "choiceNumber": 2,
                    "correctTaken": 1981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Figure-of-8 splint placement",
                    "choiceNumber": 3,
                    "correctTaken": 3604,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Open reduction and internal fixation",
                    "choiceNumber": 4,
                    "correctTaken": 836,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and gentle handling",
                    "choiceNumber": 5,
                    "correctTaken": 9580,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25203556",
                    "mediaDataId": 0,
                    "title": "Neonatal clavicular fracture:  recent 10 year study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25203556",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22123402",
                    "mediaDataId": 0,
                    "title": "Birth fracture of the clavicle.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22123402",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 163,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 16114,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 163,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 15990,
            "questionIndex": 17429,
            "questionText": "<p>A 26-year-old primigravid woman at 25 weeks gestation comes to the hospital due to preterm labor.&nbsp; For the last 6 hours, the patient has had intermittent, painful contractions but no vaginal bleeding or leakage of fluid.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/66 mm Hg, and pulse is 90/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Cardiopulmonary examination is normal.&nbsp; The uterus is nontender.&nbsp; On sterile speculum examination, the cervix is visibly 2 cm dilated and the amniotic membranes are intact.&nbsp; Fetal heart rate monitoring shows a baseline of 150/min, no decelerations, no accelerations, and minimal variability.&nbsp; Contractions occur every 2-3 minutes on tocodynamometry.&nbsp; The patient is administered indomethacin for tocolysis.&nbsp; This intervention increases this patient&#39;s risk for which of the following obstetric complications?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with frequent contractions causing cervical dilation at 25 weeks gestation is in <strong>preterm labor</strong>.&nbsp; Management of preterm labor depends on gestational age, with increased intervention required at earlier gestations due to the risks of neonatal prematurity.&nbsp; Patients at <strong>&lt;32 weeks gestation</strong> in preterm labor require:</p><ul><li><strong>indomethacin</strong> to inhibit contractions and delay delivery (ie, tocolysis).</li><li>betamethasone to promote fetal lung maturity.</li><li>magnesium sulfate to decrease the risk of cerebral palsy (ie, fetal neuroprotection).</li><li>penicillin to decrease the risk of neonatal group B <em>Streptococcus</em> infection.</li></ul><p>Although the benefits typically outweigh the risks, indomethacin tocolysis can have adverse fetal effects.&nbsp; Indomethacin, a nonspecific cyclooxygenase inhibitor, <strong>decreases prostaglandin production</strong> and leads to fetal vasoconstriction (eg, premature closure of the ductus arteriosus).&nbsp; The subsequent <strong>decreased renal perfusion</strong> and fetal oliguria can result in <strong>oligohydramnios</strong> (ie, amniotic fluid index &#8804;5 cm), particularly with prolonged administration; therefore, patients typically receive indomethacin for &#8804;48 hours.&nbsp; The oligohydramnios associated with indomethacin use is typically transient and resolves without intervention once the medication is discontinued.</p><p><strong>(Choice A)</strong>&nbsp; Although betamethasone, a corticosteroid, may transiently increase maternal glucose levels, it does not increase the risk of gestational diabetes mellitus (GDM).&nbsp; Indomethacin does not increase the risk of GDM.</p><p><strong>(Choice B)</strong>&nbsp; Although this patient has a dilated cervix, the amniotic membranes are intact, making the risk of intraamniotic infection (IAI) exceedingly low.&nbsp; In contrast, the risk is increased in patients with preterm prelabor rupture of membranes (ie, amniotic membranes not intact).&nbsp; Indomethacin does not increase the risk.&nbsp; Tocolysis is typically avoided in patients with symptomatic IAI (eg, fever, tachycardia).</p><p><strong>(Choice D)</strong>&nbsp; Risk factors for preeclampsia include chronic hypertension, diabetes mellitus, and multiple gestation but not indomethacin use.</p><p><strong>(Choice E)</strong>&nbsp; The most common cause of pulmonary edema in pregnancy is preeclampsia due to increased vascular permeability and hemodynamic dysfunction.&nbsp; Although indomethacin, like other nonsteroidal anti-inflammatory drugs, can lead to some degree of fluid retention, its use is not associated with pulmonary edema.</p><p><strong>Educational objective:</strong><br>Indomethacin tocolysis (ie, to inhibit contractions) is indicated in patients with preterm labor at &lt;32 weeks gestation.&nbsp; Indomethacin tocolysis can cause oligohydramnios and premature closure of the fetal ductus arteriosus, although its benefits typically outweigh these risks.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4239,
            "topic": "Preterm labor",
            "titleId": 4239,
            "title": "Preterm labor",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational diabetes mellitus",
                    "choiceNumber": 1,
                    "correctTaken": 212,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 2,
                    "correctTaken": 2142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oligohydramnios",
                    "choiceNumber": 3,
                    "correctTaken": 7996,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 4,
                    "correctTaken": 2376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary edema",
                    "choiceNumber": 5,
                    "correctTaken": 3946,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22370109",
                    "mediaDataId": 0,
                    "title": "Tocolytic therapy for acute preterm labor.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22370109",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26042617",
                    "mediaDataId": 0,
                    "title": "Cyclo-oxygenase (COX) inhibitors for treating preterm labour.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26042617",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 132,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16672,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 132,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 10817,
            "questionIndex": 11948,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 34-year-old woman, gravida 3 para 2, has a precipitous spontaneous vaginal delivery of a 4.2-kg (9 lb 5 oz) boy at 39 weeks gestation.&nbsp; After 15 minutes of gentle umbilical cord traction and fundal massage, the placenta is not delivered.&nbsp; Umbilical cord traction is continued; the umbilical cord abruptly avulses, and the patient suddenly develops severe abdominal pain.&nbsp; Blood pressure is 70/40 mm Hg and pulse is 62/min.&nbsp; On abdominal examination, the uterine fundus is not palpable at the umbilicus.&nbsp; There is copious vaginal bleeding with bright red blood and passage of large clots.&nbsp; On removal of the blood clots, a firm, rounded mass is visualized protruding from the vagina.</p><p><strong>Item 1 of 2</strong><br>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4513\" src=\"https://www.uworld.com/media/L29103.jpg\" ></p><p>This patient&#39;s <strong>postpartum hemorrhage</strong> and vaginal mass are concerning for <strong>uterine inversion</strong>, an obstetric emergency.&nbsp; Risk factors may include fetal macrosomia, rapid labor and delivery, and placenta accreta.&nbsp; Uterine inversion likely occurs due to <strong>excessive fundal pressure</strong> and <strong>traction on the umbilical cord</strong> prior to placental separation, which can lead to cord avulsion, as in this patient.&nbsp; The excessive traction causes the fundus to collapse into the endometrial cavity and prolapse through the cervix, resulting in a <strong>firm, rounded mass protruding</strong> through the vagina.&nbsp; As a result, the <strong>fundus</strong> is <strong>no longer palpable</strong> transabdominally.</p><p>Patients with uterine inversion typically have <strong>severe abdominal pain</strong> and heavy vaginal bleeding with possible hemorrhagic shock (eg, hypotension).&nbsp; Neurogenic shock, due to the traction effect on the surrounding peritoneum, may also occur, resulting in a paradoxical bradycardia.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"2778\">Placenta previa</a>, in which the placenta covers the cervix, can cause heavy vaginal bleeding; however, bleeding occurs antenatally, not postpartum, and is typically painless.</p><p><strong>(Choice B)</strong>&nbsp; A <a href=\"12914\">prolapsing fibroid</a> may appear as a firm, rounded mass protruding into the vagina; however, it is not typically associated with severe abdominal pain or hypotension.&nbsp; In addition, the uterine fundus would remain palpable transabdominally.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"1057\">Uterine rupture</a>, or disruption of the uterine wall, can present with severe abdominal pain and heavy bleeding; however, it is not associated with a vaginal mass.&nbsp; In addition, uterine rupture is rare in patients without prior uterine surgery (eg, myomectomy).</p><p><strong>(Choice E)</strong>&nbsp; Vaginal hematoma is a cause of postpartum hemorrhage that can appear as a firm, rounded vaginal mass.&nbsp; However, blood loss is typically hidden in the paravaginal space (ie, occult bleeding with no passage of large clots), and the uterine fundus remains palpable transabdominally.</p><p><strong>Educational objective:</strong><br>Uterine inversion, in which the uterine fundus inverts and prolapses through the cervix or vagina after delivery, typically appears as a firm, rounded mass protruding through the cervix or vagina.&nbsp; Patients can have severe abdominal pain, heavy vaginal bleeding, and a nonpalpable uterine fundus on abdominal examination.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4368,
            "topic": "Uterine inversion",
            "titleId": 4368,
            "title": "Uterine inversion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 10817,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 1,
                    "correctTaken": 1209,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prolapsed fibroid",
                    "choiceNumber": 2,
                    "correctTaken": 830,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine inversion",
                    "choiceNumber": 3,
                    "correctTaken": 16208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 4,
                    "correctTaken": 2928,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal hematoma",
                    "choiceNumber": 5,
                    "correctTaken": 460,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27386133",
                    "mediaDataId": 0,
                    "title": "Acute complete uterine inversion after controlled cord traction of placenta following vaginal delivery: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27386133",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25326075",
                    "mediaDataId": 0,
                    "title": "Total and acute uterine inversion after delivery: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25326075",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 52,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 21635,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 52,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 10818,
            "questionIndex": 11947,
            "questionText": "<p><strong>Item 2 of 2</strong><br>Two wide-bore intravenous lines are placed, and intravenous fluids are administered.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"22903\" src=\"https://www.uworld.com/media/L43620.jpg\" ></p><p><strong>Uterine inversion</strong> is treated with <strong>immediate manual replacement of the uterus</strong> by placing a hand in the vagina and pushing the prolapsed uterus back through the cervix to return it to its anatomic position.&nbsp; Delay in reduction of the prolapse can make manual uterine replacement more difficult because the uterus can become edematous and the cervix may contract around the inverted uterus.&nbsp; If the placenta is still attached to the uterine wall, as in this patient, it should not be removed until after the uterus is replaced because of the risk of massive hemorrhage <strong>(Choice E)</strong>.</p><p>Manual replacement of the uterus requires moderate uterine relaxation; therefore, <strong>uterotonics</strong> (eg, oxytocin) are <strong>discontinued</strong> because they increase uterine tone (ie, contractility) and may make manual uterine replacement impossible to perform <strong>(Choice B)</strong>.</p><p>Uterine relaxants (eg, terbutaline, nitroglycerin) are typically reserved for patients in whom initial attempts at reduction are unsuccessful because such relaxants increase the risk of persistent uterine atony (ie, bogginess) and associated postpartum hemorrhage <strong>(Choice A)</strong>.&nbsp; If attempts at manual uterine replacement fail, the next step in management is laparotomy to prevent exsanguination <strong>(Choice C)</strong>.</p><p><strong>Educational objective:</strong><br>Uterine inversion requires discontinuation of uterotonics (eg, oxytocin) and immediate manual replacement of the uterus to prevent exsanguination.&nbsp; Uterine relaxants and laparotomy may be required if initial attempts at manual reduction are unsuccessful.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4368,
            "topic": "Uterine inversion",
            "titleId": 4368,
            "title": "Uterine inversion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 10817,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administration of uterine relaxants",
                    "choiceNumber": 1,
                    "correctTaken": 1016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administration of uterotonics",
                    "choiceNumber": 2,
                    "correctTaken": 1550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergent laparotomy",
                    "choiceNumber": 3,
                    "correctTaken": 3180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Manual replacement of the uterus",
                    "choiceNumber": 4,
                    "correctTaken": 13429,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Removal of the placenta",
                    "choiceNumber": 5,
                    "correctTaken": 2449,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27386133",
                    "mediaDataId": 0,
                    "title": "Acute complete uterine inversion after controlled cord traction of placenta following vaginal delivery: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27386133",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25326075",
                    "mediaDataId": 0,
                    "title": "Total and acute uterine inversion after delivery: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25326075",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 21,
            "othersAvgTimeSpent": 15,
            "notes": null,
            "peopleTaken": 21624,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 21,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 10898,
            "questionIndex": 12034,
            "questionText": "<p>A 22-year-old woman, gravida 1 para 1, is evaluated in the postpartum unit for lower abdominal pressure and pain.&nbsp; The patient underwent an induction of labor at 41 weeks gestation due to oligohydramnios.&nbsp; She received epidural anesthesia and had a forceps-assisted vaginal delivery due to prolonged second stage of labor.&nbsp; A second-degree perineal laceration was repaired after delivery, and she had a postpartum hemorrhage that resolved with uterotonic medications.&nbsp; The patient is now 6 hours postpartum; she has been unable to void since delivery and has persistent urine dribbling while lying in bed.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 100/60 mm Hg, and pulse is 92/min.&nbsp; BMI is 33 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination reveals a firm uterine fundus and diffuse lower abdominal tenderness to palpation.&nbsp; The perineal repair is intact and there is moderate lochia.&nbsp; Deep tendon reflexes are normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s urinary symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38602\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum urinary retention</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Primiparity</li><li>Regional neuraxial anesthesia</li><li>Operative vaginal delivery</li><li>Perineal injury</li><li>Cesarean delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Small-volume voids or inability to void</li><li>Incomplete bladder emptying</li><li>Dribbling of urine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Self-limited condition</li><li>Intermittent catheterization</li></ul></td></tr></tbody></table></div><p>This patient has acute <strong>postpartum urinary retention</strong>, defined as an <strong>inability to void &#8805;6 hours after vaginal delivery</strong> or &#8805;6 hours after urinary catheter removal following cesarean delivery.&nbsp; Patients with acute urinary retention can develop a concomitant <strong>overflow incontinence</strong>, resulting in clinical features such as urinary dribbling and lower abdominal pressure from an <strong>overdistended bladder</strong>.</p><p>Postpartum urinary retention often occurs due to the following:</p><ul><li><p>Perineal trauma from a prolonged second stage of labor and/or perineal laceration that results in a <strong>pudendal nerve injury</strong>.&nbsp; Damage to the pudendal nerve can result in a decreased voiding sensation, thereby promoting urinary retention, and cause external urethral sphincter dysfunction.</p></li><li><p>Reduced sensory and motor sacral spinal cord impulses from regional neuraxial anesthesia (eg, <strong>epidural anesthesia</strong>), which can suppress the micturition reflex and decrease detrusor tone, resulting in <strong>bladder atony</strong>.</p></li></ul><p>Other risk factors include primiparity and operative (forceps-assisted) vaginal delivery.&nbsp; Management is with intermittent urethral catheterization and reassurance as retention is typically self-limited and resolves in &lt;1 week.</p><p><strong>(Choice B)</strong>&nbsp; In contrast to this patient, those with detrusor overactivity have urinary urgency followed by immediate loss of urine (urge incontinence) due to bladder spasms.</p><p><strong>(Choice C)</strong>&nbsp; Hypovolemia from postpartum hemorrhage may result in acute kidney injury due to acute tubular necrosis or renal ischemia.&nbsp; Patients typically have decreased urine production rather than urinary retention.</p><p><strong>(Choice D)</strong>&nbsp; Urethral injury may result from pelvic floor surgery or perineal laceration repair from a foreign body (eg, mesh, suture).&nbsp; Patients can have urinary retention and dribbling; however, they typically have urinary frequency, dysuria, and a slow or interrupted stream from the foreign body.</p><p><strong>(Choice E)</strong>&nbsp; Vaginal atrophy can develop postpartum and present with urinary symptoms (eg, urethral discomfort, stress urinary incontinence).&nbsp; However, vaginal atrophy is unlikely immediately postpartum (due to high estrogen levels during pregnancy) and typically occurs in women with prolonged low estrogen levels from lactational amenorrhea.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"4908\">Vesicovaginal fistula</a> may occur secondary to obstetric complications (eg, prolonged labor, operative vaginal delivery) and cause persistent urinary dribbling; however, it often takes days to develop and there is typically no associated bladder distention as urine continuously drains through the fistula.</p><p><strong>Educational objective:</strong><br>Acute postpartum urinary retention causes an inability to void as well as overflow incontinence due to pudendal nerve injury and bladder atony.&nbsp; Risk factors include prolonged labor, perineal trauma, and regional neuraxial anesthesia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 1315,
            "topic": "Urinary incontinence",
            "titleId": 1315,
            "title": "Urinary incontinence",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bladder atony",
                    "choiceNumber": 1,
                    "correctTaken": 8709,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Detrusor overactivity",
                    "choiceNumber": 2,
                    "correctTaken": 1030,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypovolemia",
                    "choiceNumber": 3,
                    "correctTaken": 245,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urethral injury",
                    "choiceNumber": 4,
                    "correctTaken": 4053,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal atrophy",
                    "choiceNumber": 5,
                    "correctTaken": 23,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vesicovaginal fistula",
                    "choiceNumber": 6,
                    "correctTaken": 2608,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30142472",
                    "mediaDataId": 0,
                    "title": "Risk factors and management of persistent postpartum urinary retention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30142472",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30158981",
                    "mediaDataId": 0,
                    "title": "Acceptable postvoid residual urine volume after vaginal delivery and its association with various obstetric parameters.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30158981",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26224379",
                    "mediaDataId": 0,
                    "title": "Delivery-related risk factors for covert postpartum urinary retention after vaginal delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26224379",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 198,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16675,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 198,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 4757,
            "questionIndex": 4757,
            "questionText": "<p>A 35-year-old woman, gravida 4 para 3, at 37 weeks gestation comes to the hospital due to leakage of fluid and painful contractions.&nbsp; The patient has had continuous vaginal leakage of clear fluid for the past 2 days and now the fluid appears green.&nbsp; Her prior 3 pregnancies were uncomplicated term vaginal deliveries, and she has not received prenatal care with this pregnancy.&nbsp; The patient has no chronic medical conditions and no known drug allergies.&nbsp; Temperature is 36.1 C (97 F), blood pressure is 120/80 mm Hg, and pulse is 76/min.&nbsp; Speculum examination shows a pool of meconium-stained fluid in the posterior fornix of the vagina.&nbsp; The cervix is 6 cm dilated, 60% effaced, and the fetal vertex is at +1 station.&nbsp; Fetal heart tracing reveals moderate variability and early decelerations with each contraction.&nbsp; Contractions occur every 2-3 minutes.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33322\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preventing neonatal group B <em>Streptococcus</em> infection</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antenatal screening</strong></p></td><td><ul><li>Rectovaginal culture at 36-38 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indications for intrapartum prophylaxis</strong></p></td><td><ul><li>GBS bacteriuria or GBS urinary tract infection in current pregnancy (regardless of treatment)</li><li>GBS-positive rectovaginal culture in current pregnancy</li><li>Unknown GBS status PLUS any of the following:<ul style=\"list-style-type:circle;\"><li>&lt;37 weeks gestation</li><li>Intrapartum fever</li><li>Rupture of membranes for &#8805;18 hours</li></ul></li><li>Prior infant with early-onset neonatal GBS infection&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Intrapartum prophylaxis</strong></p></td><td><ul><li>Intravenous penicillin</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GBS</strong> = group B <em>Streptococcus</em>.</p></td></tr></tbody></table></div><p><em>Streptococcus agalactiae</em>, or <strong>group B</strong>&nbsp;<em><strong>Streptococcus</strong></em>&nbsp;<strong>(GBS)</strong>, is a common colonizer of the maternal gastrointestinal and genital tract.&nbsp; Although GBS is typically asymptomatic in pregnant women, it can be vertically transmitted during vaginal delivery or after rupture of membranes, causing <strong>early-onset neonatal GBS infection</strong> (eg, sepsis, pneumonia).&nbsp; To prevent vertical transmission, most women are screened at 36-38 weeks gestation; those who are GBS-positive require intrapartum antibiotic prophylaxis (IAP).</p><p>Women with an <strong>unknown GBS status</strong>, such as this patient, are triaged based on risk factors.&nbsp; Most women at &#8805;37 weeks gestation do not require IAP as they are at low risk for vertical transmission, and indiscriminate antibiotic use can lead to bacterial resistance.&nbsp; In contrast, women with the following risk factors require IAP:</p><ul><li><p><strong>Rupture of membranes for &#8805;18 hours</strong> (as in this patient) because the extended time period allows for possible GBS proliferation, increased bacterial load, and prolonged fetal exposure to infected amniotic fluid&mdash;all of which increase the <strong>risk of vertical transmission</strong> and neonatal infection</p></li><li><p>Intrapartum fever, which indicates possible intraamniotic infection involving GBS</p></li><li><p>Delivery at &lt;37 weeks gestation, as the immature fetal immune system is more susceptible to infection</p></li></ul><p>Women who meet criteria for IAP are typically administered intravenous penicillin <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Amnioinfusion is used to decrease umbilical cord compression (as evidenced by variable decelerations) after rupture of membranes.&nbsp; This patient&#39;s early decelerations are caused by fetal head compression; they are normal and do not require treatment.</p><p><strong>(Choices B and D)</strong>&nbsp; This patient has a reassuring fetal heart rate tracing and is in active labor (6 cm dilated, contractions every 2-3 minutes).&nbsp; Therefore, neither cesarean delivery nor labor augmentation are indicated.</p><p><strong>Educational objective:</strong><br>Intrapartum antibiotic prophylaxis is administered to prevent neonatal group B <em>Streptococcus</em> (GBS) infection in patients with an unknown GBS status and the following risk factors for vertical transmission: rupture of membranes for &#8805;18 hours, intrapartum fever, and fetal prematurity (&lt;37 weeks gestation).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9953,
            "topic": "Group b streptococcal infection",
            "titleId": 9953,
            "title": "Group b streptococcal infection",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 711,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 4129,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management only",
                    "choiceNumber": 3,
                    "correctTaken": 3420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Labor augmentation",
                    "choiceNumber": 4,
                    "correctTaken": 3072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penicillin",
                    "choiceNumber": 5,
                    "correctTaken": 5316,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24084566",
                    "mediaDataId": 0,
                    "title": "Practice bulletins no. 139: premature rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24084566",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21088663",
                    "mediaDataId": 0,
                    "title": "Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21088663",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 239,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16652,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 32,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 239,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 17062,
            "questionIndex": 18510,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 1, comes to the office for an initial prenatal visit.&nbsp; The patient is at 16 weeks gestation by her last menstrual period and has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; For the first 2 months of her pregnancy, the patient had daily nausea and vomiting that resolved without treatment.&nbsp; She has no chronic medical conditions and has had no previous surgeries.&nbsp; Her only medication is a daily prenatal vitamin that she started taking a few weeks ago.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs are normal.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Cardiopulmonary examination is normal.&nbsp; The uterus measures 20 weeks gestation.&nbsp; Prenatal laboratory testing reveals that the patient&#39;s serum alpha-fetoprotein concentration is 3.8 multiples of the median (normal: &lt;2.5).&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31236\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neural tube defects </strong></p></td></tr><tr><td><p align=\"center\"><strong>Types </strong></p></td><td><ul><li>Anencephaly</li><li>Encephalocele</li><li>Spina bifida, myelomeningocele</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk</strong></p><p align=\"center\"><strong>factors </strong></p></td><td><ul><li>Low folic acid&nbsp;intake</li><li>Methotrexate, antiepileptics</li><li>Diabetes mellitus</li><li>Prior pregnancy with neural tube defect</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prenatal<br />screening </strong></p></td><td><ul><li>2nd-trimester ultrasonography</li><li>Maternal serum &alpha;-fetoprotein</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention </strong></p></td><td><ul><li>Average risk: 0.4 mg folic acid daily</li><li>High risk: 4 mg folic acid daily</li></ul></td></tr></tbody></table></div><p><strong>Neural tube defects</strong> (NTDs) are a common congenital anomaly and can vary from surgically correctable, minor defects (eg, <a href=\"2460\">spina bifida</a>) to major defects (eg, <a href=\"6242\">anencephaly</a>) that are incompatible with life.&nbsp; Screening for NTDs occurs at 15-20 weeks gestation with measurement of <strong>maternal serum alpha-fetoprotein (MSAFP)</strong>, a glycoprotein produced by the fetus.&nbsp; MSAFP levels are reported in multiples of the median (MoM) using unaffected pregnancies at the same gestational age as reference.</p><p>An <strong>abnormally elevated MSAFP</strong> level (&#8805;2.5 MoM), as in this patient, suggests an NTD because AFP leaks more readily through a defect to become concentrated in the amniotic fluid and maternal circulation.&nbsp; However, an elevated level may also occur due to benign causes such as <strong>multiple gestation</strong> (ie, 2 fetuses each producing AFP) and <strong>incorrect gestational age dating</strong> (most common cause).&nbsp; These are both potential explanations in this patient with a uterine size-greater-than-dates discrepancy and late presentation to prenatal care.</p><p>Therefore, an abnormal MSAFP level requires <strong>fetal ultrasound</strong>, which can detect multiple gestations, determine an accurate gestational age, and visualize fetal CNS structures.</p><p><strong>(Choice A)</strong>&nbsp; AFP and CA-125 are ovarian tumor markers, but both are commonly elevated in pregnancy.&nbsp; CA-125 levels are not measured in young patients (ie, those at low cancer risk) unless they have undergone surgery for ovarian cancer and require levels to follow disease progression.</p><p><strong>(Choice C)</strong>&nbsp; Folic acid supplementation is recommended starting &#8805;1 month before conception as the neural tube closes very early in pregnancy, often before patients are aware of being pregnant.&nbsp; However, increasing intake at 16 weeks gestation will not benefit this patient because neural tube closure is complete by 5-6 weeks gestation.&nbsp; In addition, increasing the dosage is not recommended because prenatal vitamins contain other components (eg, vitamin A) that are dangerous if taken in excess.</p><p><strong>(Choice D)</strong>&nbsp; A quantitative &#946;-hCG level can be measured in the first trimester to evaluate for suspected abnormal pregnancies (eg, ectopic, hydatidiform mole).&nbsp; Second-trimester levels, which cannot assess fetal status, do not affect obstetric management.</p><p><strong>(Choice E)</strong>&nbsp; A repeat MSAFP level, even if normal, cannot exclude an NTD due to a tendency for values to regress to the mean, leading to a falsely reassuring result.</p><p><strong>Educational objective:</strong><br>Elevated maternal serum alpha-fetoprotein (MSAFP) levels can identify fetuses with neural tube defects but may be due to other benign causes (eg, multiple gestation, incorrect dating).&nbsp; Therefore, patients with elevated levels require fetal ultrasound.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12760,
            "topic": "Neural tube defects",
            "titleId": 12760,
            "title": "Neural tube defects",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CA-125 level",
                    "choiceNumber": 1,
                    "correctTaken": 87,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal ultrasound",
                    "choiceNumber": 2,
                    "correctTaken": 13938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase prenatal vitamin dose",
                    "choiceNumber": 3,
                    "correctTaken": 198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG level",
                    "choiceNumber": 4,
                    "correctTaken": 1349,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat serum alpha-fetoprotein concentration",
                    "choiceNumber": 5,
                    "correctTaken": 1044,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27235920",
                    "mediaDataId": 0,
                    "title": "Screening for open neural tube defects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27235920",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29189693",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 187: neural tube defects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29189693",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 158,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16616,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 158,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 17065,
            "questionIndex": 18513,
            "questionText": "<p>A 43-year-old primigravida at 37 weeks gestation comes to the labor and delivery department for evaluation of a severe headache that began this morning.&nbsp; The patient now has dark spots in her vision but no epigastric pain, nausea, or vomiting.&nbsp; She also has irregular, nonpainful contractions but no vaginal bleeding or loss of fluid.&nbsp; The patient has myasthenia gravis and takes pyridostigmine; she has no other chronic medical conditions or pregnancy complications.&nbsp; Rectovaginal screening for group B <em>Streptococcus</em> was positive at 35 weeks gestation.&nbsp; Blood pressure is 184/106 mm Hg and pulse is 88/min.&nbsp; The abdomen is soft, gravid, and nontender.&nbsp; The cervix is 3 cm dilated and 50% effaced, and the fetal vertex is at -1 station.&nbsp; Fetal heart rate tracing demonstrates a baseline of 130/min, moderate variability, multiple accelerations, and no decelerations.&nbsp; Tocodynamometry reveals contractions every 8-10 minutes.&nbsp; The patient is admitted for induction of labor due to preeclampsia with severe features.&nbsp; Which of the following medications is contraindicated in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35804\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Medications to avoid in myasthenia gravis</strong></p></td></tr><tr><td><ul><li>Magnesium sulfate</li><li>Fluoroquinolones, aminoglycosides</li><li>Neuromuscular blocking agents</li><li>CNS depressants</li><li>Muscle relaxants</li><li>Calcium channel blockers</li><li>Beta blockers</li><li>Opioids</li><li>Statins</li></ul></td></tr></tbody></table></div><p><strong>Myasthenia gravis</strong> (MG) is a neuromuscular junction disorder caused by autoantibodies against acetylcholine receptors in skeletal muscle.&nbsp; MG typically does not increase the risk for obstetric complications, and well-controlled disease can remain stable throughout pregnancy (a small subset of women may have a flare in the first trimester or postpartum).&nbsp; Patients may continue to take acetylcholinesterase inhibitors (eg, pyridostigmine) during pregnancy; additional medications may be discontinued based on teratogenicity and disease control during the preconception period.</p><p>When obstetric complications do occur in patients with MG, management is tailored to avoid disease exacerbation (eg, respiratory muscle weakness).&nbsp; This patient has a commonly seen obstetric complication, <strong>preeclampsia with severe features</strong> (eg, hypertension, headache, visual changes).&nbsp; In patients without MG, management of preeclampsia with severe features includes magnesium sulfate for seizure prophylaxis.&nbsp; However, in patients with MG, <strong>magnesium sulfate</strong> is <strong>contraindicated</strong> because it may trigger a <strong>myasthenic crisis</strong> (eg, oropharyngeal muscle weakness, respiratory failure requiring intubation) due to inhibition of acetylcholine release at the neuromuscular junction.&nbsp; In these patients, seizure prophylaxis is with valproic acid.</p><p><strong>(Choice A)</strong>&nbsp; Acetaminophen is not contraindicated in pregnancy or in patients with MG and can be used to improve this patient&#39;s headache.</p><p><strong>(Choice B)</strong>&nbsp; Antihypertensive therapy is used in pregnant patients with severe hypertension (ie, systolic blood pressure &#8805;160 mm Hg or diastolic blood pressure &#8805;110 mm Hg) to decrease the risk of stroke.&nbsp; Although some antihypertensives (eg, beta blockers, calcium channel blockers) can exacerbate muscle weakness in patients with MG, hydralazine does not and is not contraindicated in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Oxytocin is used for labor augmentation and induction.&nbsp; Contraindications to oxytocin include prior classical cesarean delivery (due to the risk of uterine rupture) or fetal heart rate decelerations, which are not seen in this patient.&nbsp; MG is not a contraindication to oxytocin use.</p><p><strong>(Choice E)</strong>&nbsp; Intrapartum penicillin is administered to patients with positive rectovaginal screening for group B <em>Streptococcus</em> to decrease the risk of neonatal transmission.&nbsp; Although some antibiotics (eg, azithromycin, gentamicin) can worsen symptoms of MG, penicillin typically does not and, therefore, is not contraindicated in this patient.</p><p><strong>Educational objective:</strong><br>Magnesium sulfate, commonly used in obstetrics for seizure prophylaxis (eg, in preeclampsia with severe features), is contraindicated in patients with myasthenia gravis because it may trigger a myasthenic crisis due to the inhibition of acetylcholine release.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetaminophen",
                    "choiceNumber": 1,
                    "correctTaken": 2848,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydralazine",
                    "choiceNumber": 2,
                    "correctTaken": 2662,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 3,
                    "correctTaken": 6056,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin",
                    "choiceNumber": 4,
                    "correctTaken": 4798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penicillin",
                    "choiceNumber": 5,
                    "correctTaken": 246,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28280642",
                    "mediaDataId": 0,
                    "title": "Severe preeclampsia in the setting of myasthenia gravis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28280642",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31435279",
                    "mediaDataId": 0,
                    "title": "Myasthenia gravis and preeclampsia: dot all the I&#39;s and cross all the T&#39;s.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31435279",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23563874",
                    "mediaDataId": 0,
                    "title": "Myasthenia gravis and pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23563874",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16610,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 36,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 78,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 13763,
            "questionIndex": 15157,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 37 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has noticed less fetal movement than normal.&nbsp; She has had no vaginal bleeding, contraction pain, or leakage of fluid.&nbsp; The patient has no chronic medical conditions and takes a daily prenatal vitamin.&nbsp; She previously smoked a pack of cigarettes daily but decreased to a quarter pack daily after becoming pregnant.&nbsp; Her prenatal course has been uncomplicated; first-trimester ultrasound showed a viable intrauterine pregnancy and multiple intramural and submucosal leiomyomas.&nbsp; Vital signs are normal.&nbsp; Fundal height is 38 cm.&nbsp; A nonstress test is reactive.&nbsp; Ultrasound shows a fetus in frank breech presentation with an estimated fetal weight at the 80th percentile for gestational age, a fundal placenta, and an amniotic fluid index of 15 cm.&nbsp; Which of the following is the most likely cause of this patient&#39;s fetal breech presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T41478\" style=\"overflow-x:auto;\"><table class=\"table-default-style\" style=\"width:384px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Breech presentation</strong></p></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Breech<br>types</strong></p></td><td style=\"width: 80%;\"><ul><li>Frank: hips flexed &amp; knees extended (buttock presenting)</li><li>Complete: hips &amp; knees flexed</li><li>Incomplete: 1 or both hips not flexed (feet presenting)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk<br>factors</strong></p></td><td><ul><li>Advanced maternal age (&#8805;35)</li><li>Uterine didelphys, septate uterus</li><li>Uterine leiomyomas</li><li>Fetal anomalies (eg, anencephaly)</li><li>Preterm (&lt;37 weeks gestation)</li><li>Oligohydramnios/polyhydramnios</li><li>Placenta previa</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>External cephalic version</li><li>Cesarean delivery</li></ul></td></tr></tbody></table></div><p><strong>Breech presentation</strong> occurs when the <a href=\"16678\">buttocks</a> or <a href=\"16679\">feet</a> are the fetal parts closest to the maternal cervix.&nbsp; It is a common type of fetal malpresentation and has an increased risk of complications during vaginal delivery (eg, delivery trauma, umbilical cord prolapse, head entrapment).&nbsp; Variable fetal presentation, including breech, is normal during early pregnancy due to the small fetal size relative to the amniotic fluid volume; with increasing gestational age (particularly at term gestations), the fetus typically develops a cephalic presentation, thereby optimizing chances of an uncomplicated vaginal delivery <strong>(Choice C)</strong>.</p><p>Fetal malpresentation (eg, breech) can occur when either fetal mobility or maternal anatomy (ie, fixation of the presenting part in the pelvic inlet) is affected.&nbsp; A common <strong>risk factor</strong> for breech presentation (as seen in this patient) is <strong>uterine leiomyomas</strong>, particularly <a href=\"2335\">submucosal fibroids</a> because they can <strong>distort the uterine cavity</strong> and <strong>limit fetal mobility</strong>.&nbsp; In addition, large leiomyomas in the lower uterine segment can become space occupying and <strong>prevent fetal cephalic engagement</strong>.</p><p>Patients with breech presentation and no contraindications to vaginal delivery (eg, placenta previa, prior classical cesarean delivery) can be offered an external cephalic version (ie, manual rotation of the fetus to cephalic presentation) at &#8805;37 weeks gestation.</p><p><strong>(Choice A)</strong>&nbsp; Polyhydramnios (amniotic fluid index &#8805;24 cm) and oligohydramnios (amniotic fluid index &#8804;5 cm) are risk factors for breech presentation because extremes of amniotic fluid volume can cause fetal hypermobility (polyhydramnios) or hypomobility (oligohydramnios).&nbsp; This patient&#39;s amniotic fluid index is normal.</p><p><strong>(Choices B and E)</strong>&nbsp; Fetal growth restriction and its causes (eg, tobacco use) are risk factors for breech presentation because small fetal size can result in hypermobility.&nbsp; Although this patient uses tobacco, the fetal weight is normal; therefore, it is not likely the cause of this breech presentation.</p><p><strong>(Choice D)</strong>&nbsp; Placenta previa is a risk factor for breech presentation because the placenta occupies the lower portion of the uterus and prevents fetal engagement.&nbsp; This patient has a fundal placenta.</p><p><strong>Educational objective:</strong><br>Breech presentation occurs when the buttocks or feet are the fetal parts closest to the maternal cervix.&nbsp; A risk factor for breech presentation is uterine leiomyomas, which can distort the uterine cavity, thereby limiting fetal mobility and preventing fetal cephalic engagement.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 25353,
            "topic": "Fetal malpresentation",
            "titleId": 25353,
            "title": "Fetal malpresentation",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniotic fluid index",
                    "choiceNumber": 1,
                    "correctTaken": 1367,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estimated fetal weight",
                    "choiceNumber": 2,
                    "correctTaken": 1243,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational age",
                    "choiceNumber": 3,
                    "correctTaken": 269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental location",
                    "choiceNumber": 4,
                    "correctTaken": 768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tobacco use",
                    "choiceNumber": 5,
                    "correctTaken": 1334,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine leiomyomas",
                    "choiceNumber": 6,
                    "correctTaken": 9101,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28176014",
                    "mediaDataId": 0,
                    "title": "Breech presentation at term and associated obstetric risks factors—a nationwide population based cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28176014",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26660231",
                    "mediaDataId": 0,
                    "title": "Breech presentation: its predictors and consequences.  An analysis of the Hungarian Tauffer Obstetric Database (1996-2011).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26660231",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24784711",
                    "mediaDataId": 0,
                    "title": "Common determinants of breech presentation at birth in singletons: a population-based study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24784711",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 173,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 14082,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 173,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 13765,
            "questionIndex": 15159,
            "questionText": "<p>A 37-year-old woman comes to the emergency department due to persistent nausea and vomiting.&nbsp; The patient has had intermittent nausea for the past week and constant nausea and vomiting for the past 2 days.&nbsp; Now, she is unable to tolerate any solids or liquids.&nbsp; The patient has had no fever, chills, abdominal pain, diarrhea, constipation, or sick contacts.&nbsp; She has well-controlled chronic hypertension and hypothyroidism.&nbsp; The patient has had no surgeries.&nbsp; She is sexually active and uses condoms intermittently.&nbsp; The patient smokes half a pack of cigarettes daily but does not use alcohol or recreational drugs.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 130/88 mm Hg, and pulse is 108/min.&nbsp; Mucous membranes are dry and capillary refill time is delayed.&nbsp; The thyroid is nontender and diffusely enlarged on palpation.&nbsp; Cardiac examination shows sinus tachycardia and no murmurs.&nbsp; The abdomen is nontender and nondistended.&nbsp; A urine pregnancy test is positive.&nbsp; Urinalysis is positive for ketones.&nbsp; Pelvic ultrasound reveals a viable, 8-week intrauterine twin gestation.&nbsp; Which of the following is the most significant risk factor for this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38816\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hyperemesis gravidarum</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Hydatidiform mole</li><li>Multifetal gestation</li><li>History of hyperemesis gravidarum</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Severe, persistent vomiting</li></ul><ul><li>&gt;5% loss of prepregnancy weight</li><li>Dehydration</li><li>Orthostatic hypotension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory abnormalities</strong></p></td><td><ul><li>Ketonuria</li><li>Hypochloremic metabolic alkalosis</li><li>Hypokalemia</li><li>Hemoconcentration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Admission to hospital</li><li>Antiemetics &amp; intravenous fluids</li></ul></td></tr></tbody></table></div><p>This patient has <strong>hyperemesis gravidarum</strong>, a severe form of persistent <strong>nausea and vomiting in pregnancy</strong> that is often characterized by dehydration (eg, dry mucous membranes, delayed capillary refill, tachycardia) and hypoglycemia (as evidenced by ketonuria).&nbsp; Additional clinical features may include orthostatic hypotension, electrolyte abnormalities, and a &gt;5% loss of prepregnancy weight.&nbsp; Hyperemesis gravidarum typically occurs during the first trimester and early portions of the second trimester.</p><p>A common <strong>risk factor</strong> for hyperemesis gravidarum is a <strong>twin (multiple) gestation</strong>; other risk factors include hyperemesis gravidarum in a prior pregnancy, a hydatidiform mole, and a history of migraines or motion sickness.&nbsp; Twin gestations are thought to be at an increased risk for hyperemesis gravidarum due to <strong>elevated hCG and progesterone concentrations</strong> from a larger placental volume.&nbsp; hCG levels (which peak at the same time as hyperemesis gravidarum symptoms) may be a cause for increased nausea.&nbsp; Elevated progesterone levels, which relax smooth muscle tone at the lower esophageal sphincter (ie, gastroesophageal reflux) and in the stomach (ie, delayed gastric emptying), can cause increased or persistent vomiting.</p><p>Nausea and vomiting in pregnancy typically resolve spontaneously by the second trimester and can be managed with antiemetics and dietary changes (eg, small meals).&nbsp; Patients with hyperemesis gravidarum typically require treatment for their electrolyte abnormalities and hypovolemia and are placed on multiple scheduled antiemetics.</p><p><strong>(Choice A)</strong>&nbsp; Chronic hypertension is a risk factor for preeclampsia, fetal growth restriction, and abruptio placentae.&nbsp; It is not a risk factor for hyperemesis gravidarum.</p><p><strong>(Choice B)</strong>&nbsp; Hyperemesis gravidarum may cause a transient hyperthyroidism because elevated hCG levels share a similar subunit to TSH and, therefore, can have some thyroid-stimulating activity.&nbsp; Maternal hypothyroidism does not increase the risk of hyperemesis gravidarum.</p><p><strong>(Choice C)</strong>&nbsp; Hyperemesis gravidarum is more common in young women during their first pregnancy, not those of advanced (&gt;35) maternal age.</p><p><strong>(Choice E)</strong>&nbsp; Tobacco use protects against hyperemesis gravidarum, likely because it increases the metabolism of estrogen and thereby decreases serum estrogen levels.</p><p><strong>Educational objective:</strong><br>Hyperemesis gravidarum is a severe form of nausea and vomiting in pregnancy that typically occurs during the first trimester.&nbsp; A common risk factor is a twin gestation due to elevated hCG and progesterone levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12216,
            "topic": "Multiple gestation",
            "titleId": 12216,
            "title": "Multiple gestation",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic hypertension",
                    "choiceNumber": 1,
                    "correctTaken": 454,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal age",
                    "choiceNumber": 3,
                    "correctTaken": 827,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple gestation",
                    "choiceNumber": 4,
                    "correctTaken": 13596,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tobacco use",
                    "choiceNumber": 5,
                    "correctTaken": 1006,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "11041443",
                    "mediaDataId": 0,
                    "title": "Hyperemesis gravidarum: a current review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/11041443",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28641304",
                    "mediaDataId": 0,
                    "title": "Hyperemesis gravidarum: a review of recent literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28641304",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16685,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 92,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 14192,
            "questionIndex": 15599,
            "questionText": "<p>A 27-year-old woman comes to the emergency department due to vaginal spotting.&nbsp; The patient recently learned she was pregnant and is at 9 weeks gestation based on a sure, regular last menstrual period.&nbsp; She has had dark red vaginal spotting for the past day but no abdominal pain, cramping, or passage of tissue.&nbsp; The patient had chlamydial cervicitis as a teenager but has no chronic medical conditions.&nbsp; She has started taking a daily prenatal vitamin and does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 120/70 mm Hg and pulse is 72/min.&nbsp; Pelvic examination shows a 14-week-sized uterus, a visibly closed cervix, and minimal dark red discharge from the cervical os.&nbsp; Urine pregnancy test is positive.&nbsp; Transvaginal ultrasound is shown below:</p><p><img draggable=\"false\" id=\"19701\" src=\"https://www.uworld.com/media/U44852.jpg\" ></p><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"19702\" src=\"https://www.uworld.com/media/L44852.jpg\" ></p><p>This patient&#39;s vaginal spotting and a <strong>uterine size greater than gestational age</strong> (eg, 14 weeks size at 9 weeks gestation) are due to a <strong>complete hydatidiform mole</strong>.&nbsp; Complete hydatidiform mole pregnancies result from an abnormal fertilization of an empty ovum either by 2 sperm or by 1 sperm&nbsp;that subsequently duplicates its genome.&nbsp; This abnormal fertilization leads to trophoblastic proliferation and hydropic villi with no associated fetal development.&nbsp; The uncontrolled molar tissue proliferation and endometrial blood collection can cause <strong>first-trimester vaginal bleeding</strong>, a uterine size&ndash;date discrepancy, and markedly elevated &#946;-hCG levels (eg, &gt;100,000 mIU/mL).</p><p>The characteristic ultrasound finding of a complete hydatidiform mole is an endometrium with a &#x22;Swiss cheese&#x22; or &#x22;<strong>snowstorm&#x22; appearance</strong>.&nbsp; This appearance is due to cystic hydropic villi that create a heterogenous mass with anechoic spaces but <strong>no fetus</strong> or amniotic fluid.&nbsp; Additional ultrasound findings may include <strong>theca lutein cysts</strong>: large, bilateral, multilocular cysts that occur due to ovarian hyperstimulation.</p><p>Treatment is with suction curettage; due to the risk of malignant transformation (eg, choriocarcinoma), patients are followed with serial monitoring until the hCG level is undetectable.</p><p><strong>(Choice A)</strong>&nbsp; Adenomyosis, an abnormal collection of endometrial glands and stroma within the uterine myometrium, can cause a symmetrically enlarged (globular) uterus.&nbsp; Ultrasound may show myometrial thickening with an unaffected endometrium, not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; An <a href=\"19703\">anembryonic gestation</a>, a pregnancy with no embryonic development, can present with vaginal spotting.&nbsp; However, it typically does not cause a uterine size-date discrepancy.&nbsp; Ultrasound shows an empty hypoechoic gestational sac (ie, gestational sac &#8805;25 mm with no embryo or yolk sac).</p><p><strong>(Choice C)</strong>&nbsp; An <a href=\"19704\">ectopic pregnancy</a> implants outside the uterus (eg, in the fallopian tube) and can present with vaginal spotting.&nbsp; Because there is no intrauterine pregnancy, the uterus is typically smaller than gestational age.&nbsp; Ultrasound shows a thin endometrium and an adnexal mass (embryo).</p><p><strong>(Choice E)</strong>&nbsp; Although <a href=\"19705\">twin pregnancies</a> present with a uterine size-date discrepancy, an ultrasound would show 2 fetuses rather than a &#x22;snowstorm&#x22; appearance.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"19706\">Uterine leiomyoma</a> can cause an irregularly enlarged uterus and an elevated risk of spontaneous abortion (eg, vaginal bleeding).&nbsp; Ultrasound shows well-circumscribed masses in the myometrium and a fetus.</p><p><strong>Educational objective:</strong><br>Complete hydatidiform moles typically present with first-trimester vaginal bleeding, uterine size greater than gestational age, and ultrasound with a &#x22;snowstorm&#x22; appearance and no fetus.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adenomyosis",
                    "choiceNumber": 1,
                    "correctTaken": 69,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anembryonic gestation",
                    "choiceNumber": 2,
                    "correctTaken": 178,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 3,
                    "correctTaken": 74,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 4,
                    "correctTaken": 16345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Twin pregnancy",
                    "choiceNumber": 5,
                    "correctTaken": 47,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine leiomyoma",
                    "choiceNumber": 6,
                    "correctTaken": 59,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28287945",
                    "mediaDataId": 0,
                    "title": "Gestational trophoblastic disease: clinical and imaging features.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28287945",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26588240",
                    "mediaDataId": 0,
                    "title": "Clinical presentation of complete hydatidiform mole and partial hydatidiform mole at a regional trophoblastic disease center in the United States over the past 2 decades.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26588240",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29083593",
                    "mediaDataId": 0,
                    "title": "Hydatidiform mole.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29083593",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 56,
            "othersAvgTimeSpent": 27,
            "notes": null,
            "peopleTaken": 16772,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 97,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 56,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 17955,
            "questionIndex": 19415,
            "questionText": "<p>A 30-year-old woman, gravida 2 para 1, at 28 weeks gestation is evaluated in the emergency department for abdominal pain.&nbsp; The patient&#39;s pain is severe and began abruptly this morning in the midepigastrium, but now radiates to the entire abdomen.&nbsp; She has had nausea, but no vomiting, vision changes, headache, vaginal bleeding, or leakage of fluid.&nbsp; The patient has had no prenatal care during this pregnancy and her prior pregnancy ended in a cesarean delivery for failed induction of labor.&nbsp; She has a history of tobacco use, polysubstance drug use, and peptic ulcer disease.&nbsp; Temperature is 37 C (98.7 F), blood pressure is 150/94 mm Hg, and pulse is 118/min.&nbsp; The patient is in distress and is sweating profusely.&nbsp; The abdomen is soft and gravid.&nbsp; The uterine contour is smooth, rigid, and diffusely tender.&nbsp; Tocometry shows contractions every 1-2 minutes.&nbsp; Which of the following is the most likely cause of this patient&#39;s clinical presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61669\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Abruptio placentae</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Premature placental separation from uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Hypertension, preeclampsia</li><li>Abdominal trauma</li><li>Cocaine or tobacco use</li><li>Prior abruptio placentae</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Sudden-onset vaginal bleeding</li><li>Abdominal pain</li><li>High-frequency contractions</li><li>Tender, firm uterus</li></ul></td></tr></tbody></table></div><p>This patient with acute abdominal pain and a rigid, diffusely tender uterus likely has <strong>abruptio placentae</strong>, the premature separation of the placenta from the uterine wall.&nbsp; Although most patients develop vaginal bleeding, up to 20% have a <a href=\"1056\">concealed abruption</a>, in which there is no visible bleeding.&nbsp; Patients with concealed abruptions typically have severe focal pain at the location of the placenta (such as this patient with mid-epigastric pain, which suggests a fundal placenta) that then progresses to diffuse uterine tenderness.</p><p><strong>Risk factors</strong> for placental abruption include <strong>cocaine and tobacco use</strong>, as these substances are potent vasoconstrictors that readily cross the placenta and cause <strong>placental vasoconstriction and ischemia</strong>.&nbsp; The ischemia can then cause necrosis and <strong>hemorrhage at the uteroplacental interface</strong>, resulting in the subsequent detachment of the placenta from the uterine wall.&nbsp; As blood accumulates between the placenta and uterine wall, the intrauterine pressure increases (leading to a distended, tender uterus) and induces uterine irritability (triggering <strong>high-frequency contractions</strong>).</p><p>Severe cases of placental abruption can lead to maternal hemorrhage, fetal hypoxia and demise, and disseminated intravascular coagulation.&nbsp; Management is dependent on maternal and fetal stability.</p><p><strong>(Choice A)</strong>&nbsp; Degeneration of a <a href=\"1140\">uterine leiomyoma</a> may occur during pregnancy and present with focal pain.&nbsp; However, this patient&#39;s uterine contour is smooth, making this diagnosis less likely.&nbsp; In addition, fibroid degeneration does not typically cause uterine rigidity or high-frequency contractions.</p><p><strong>(Choice B)</strong>&nbsp; Peptic ulcer perforation can present with sudden-onset, midepigastric pain that becomes diffuse.&nbsp; However, patients typically have peritoneal signs (eg, rebound, guarding) due to spillage of caustic gastric contents into the peritoneal cavity.&nbsp; This patient&#39;s abdomen is soft.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"28624\">Uterine rupture</a> can occur in patients with prior cesarean delivery due to separation of inelastic uterine scar tissue.&nbsp; Although patients have acute pain and uterine tenderness, their contractions are typically irregular and decreasing in intensity because ruptured myometrial muscle cannot contract in unison.</p><p><strong>(Choice E)</strong>&nbsp; Uterine incarceration, entrapment of the uterus between the pubic symphysis and sacral promontory, is a rare condition typically occurring at &lt;20 weeks gestation.&nbsp; Patients have constant lower abdominal pain that radiates to the back and urinary retention due to bladder obstruction.</p><p><strong>Educational objective:</strong><br>Abruptio placentae is the premature separation of the placenta from the uterine wall prior to fetal delivery.&nbsp; Patients typically have acute abdominal pain; a rigid, tender uterus; and high-frequency contractions.&nbsp; Risk factors include cocaine and tobacco use, which cause placental vasoconstriction, ischemia, and hemorrhage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Degeneration of a uterine leiomyoma",
                    "choiceNumber": 1,
                    "correctTaken": 747,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perforation of a peptic ulcer",
                    "choiceNumber": 2,
                    "correctTaken": 2504,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental vasoconstriction and ischemia",
                    "choiceNumber": 3,
                    "correctTaken": 9738,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Separation of inelastic uterine scar tissue",
                    "choiceNumber": 4,
                    "correctTaken": 3237,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine entrapment under the pubic symphysis",
                    "choiceNumber": 5,
                    "correctTaken": 407,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21241259",
                    "mediaDataId": 0,
                    "title": "Placental abruption: epidemiology, risk factors and consequences.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21241259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 90,
            "notes": null,
            "peopleTaken": 16633,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 93,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 13378,
            "questionIndex": 14756,
            "questionText": "<p>A 21-year-old woman is evaluated for nausea, vomiting, and a severe headache.&nbsp; The patient developed a headache last night after getting out of bed and walking to the newborn nursery.&nbsp; Her headache has not improved with acetaminophen or ibuprofen, and the only thing that makes it better is lying down and sleeping.&nbsp; Now she has a severe headache, nausea, and vomiting whenever she gets out of bed.&nbsp; The patient has had no dizziness, changes in vision, or loss of consciousness.&nbsp; She had a spontaneous vaginal delivery 2 days ago after an induction of labor for gestational hypertension.&nbsp; She had an epidural placed for analgesia that was removed immediately after delivery.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 136/88 mm Hg, and pulse is 108/min.&nbsp; The patient has neck stiffness and is unable to sit up due to severe nausea.&nbsp; There is no papilledema, and the pupils are equal and reactive.&nbsp; Bilateral lower extremities have pitting edema to the knees.&nbsp; Deep tendon reflexes are 2+.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50126\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postdural puncture headache</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>After lumbar puncture or neuraxial anesthesia</li><li>Positional (worse when upright, improves when supine)</li></ul><ul><li>Neck stiffness</li><li>Photophobia, diplopia</li><li>Hearing loss, tinnitus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Typically self-limited</li><li>Epidural blood patch</li></ul></td></tr></tbody></table></div><p>This postpartum patient with a severe headache after recent epidural anesthesia most likely has a <strong>postdural puncture headache</strong>.&nbsp; During placement of neuraxial anesthesia, unintentional dural puncture may occur, causing cerebrospinal fluid leakage, low cerebrospinal fluid pressure, and resultant slight herniation of the brain and brainstem.&nbsp; Therefore, patients can develop a <strong>positional headache</strong> (ie, headache <strong>worsens when sitting or standing</strong> and <strong>improves with lying down</strong>), which correlates with the increased and decreased herniation/pressure on the brain, within 72 hours of the procedure.&nbsp; Other associated symptoms may include nausea, vomiting, and neck stiffness.</p><p>Most postdural puncture headaches are self-limited; however, patients with severe symptoms that interfere with activities of daily living can be treated with an epidural blood patch.</p><p><strong>(Choice A)</strong>&nbsp; Bacterial meningitis can occur as a complication of epidural placement and present with headache and neck stiffness; this diagnosis is unlikely because this patient has no fever or altered mental status.</p><p><strong>(Choice B)</strong>&nbsp; Benign paroxysmal positional vertigo presents with positional nausea and vomiting (and occasionally headache), but this patient has no dizziness, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Migraine headaches can be associated with nausea, vomiting, and neck stiffness; they are often improved with sleep and being in a dark room.&nbsp; However, patients do not typically have worse pain with standing (ie, not positional) and do not have the frequency of headache seen in this patient (ie, every time she stands).</p><p><strong>(Choice E)</strong>&nbsp; Preeclampsia with severe features can develop postpartum, particularly in patients with gestational hypertension, and present with headache and edema.&nbsp; However, headaches due to preeclampsia are not positional.&nbsp; In addition, this patient is normotensive with normal deep tendon reflexes, making this diagnosis less likely.</p><p><strong>(Choice F)</strong>&nbsp; Tension-type headaches may be associated with neck stiffness, but the pain is typically bandlike around the head and not altered by positioning.</p><p><strong>Educational objective:</strong><br>Postdural puncture headaches after neuraxial anesthesia (eg, epidural) occur due to unintentional dural puncture.&nbsp; Patients typically develop a positional headache (ie, worsens when upright, improves when supine) within 72 hours of the procedure and often have associated nausea, vomiting, and neck stiffness.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23383,
            "topic": "Postpartum complication",
            "titleId": 23383,
            "title": "Postpartum complication",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial meningitis",
                    "choiceNumber": 1,
                    "correctTaken": 1824,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Benign paroxysmal positional vertigo",
                    "choiceNumber": 2,
                    "correctTaken": 264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Migraine with aura",
                    "choiceNumber": 3,
                    "correctTaken": 320,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postdural puncture headache",
                    "choiceNumber": 4,
                    "correctTaken": 13151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia with severe features",
                    "choiceNumber": 5,
                    "correctTaken": 1252,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tension-type headache",
                    "choiceNumber": 6,
                    "correctTaken": 83,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12734154",
                    "mediaDataId": 0,
                    "title": "PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12734154",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28131118",
                    "mediaDataId": 0,
                    "title": "Postdural puncture headache: an evidence-based approach.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28131118",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 197,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16894,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 197,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 10928,
            "questionIndex": 12064,
            "questionText": "<p>A 17-year-old girl, gravida 1 para 0, at 37 weeks gestation comes to the emergency department with headache, blurry vision, and fatigue.&nbsp; The patient has not had a prenatal visit for the past month due to final exams in school.&nbsp; She has no chronic medical conditions, and her only medication has been a daily prenatal vitamin.&nbsp; Blood pressure is 190/96 mm Hg and pulse is 106/min.&nbsp; Urinalysis shows 4+ protein.&nbsp; Physical examination shows increased ankle clonus but no neurologic deficits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">8.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">56,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">12 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Lactate dehydrogenase, serum</td><td style=\"vertical-align:middle;\">1,648 U/L</td></tr></tbody></table><p>The patient is admitted to labor and delivery for induction of labor and undergoes a spontaneous vaginal delivery of a male infant.&nbsp; Which of the following complications is most likely present in the neonate?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"46208\" src=\"https://www.uworld.com/media/L71726.png\" ></p><p>This pregnant patient with severe-range hypertension (systolic blood pressure &#8805;160 mm Hg or diastolic blood pressure &#8805;110 mm Hg) and proteinuria has <strong>preeclampsia with severe features</strong>, which likely occurs due to abnormal placental development.&nbsp; Under normal conditions, early cytotrophoblast invasion remodels the uterine spiral arteries into high-flow, low-resistance vessels that increase oxygen and nutrient delivery to the growing fetus and placenta.&nbsp; In contrast, <a href=\"38603\">abnormal cytotrophoblast invasion</a> in preeclampsia results in low-flow, high-resistance vessels that cause <strong>decreased placental perfusion</strong>.</p><p>During the first and second trimesters, the decreased placental perfusion is often subtle and not clinically noticeable because the placenta can keep up with the metabolic demands of the fetus.&nbsp; However, during the third trimester, there is rapid fetal growth (~0.2 kg [0.4 lb]/week), and the chronically under-perfused placenta <strong>cannot provide adequate oxygen</strong> to the fetus.&nbsp; In patients with preeclampsia, this <strong>uteroplacental insufficiency</strong> often coincides with the onset of <strong>wide-spread maternal vasoconstriction</strong>, which can manifest as <strong>hypertension</strong> and signs of <strong>end-organ damage</strong>, such as headache, proteinuria, thrombocytopenia, and hemolysis (eg, anemia, elevated lactate dehydrogenase).</p><p>The addition of vasoconstriction on the already under-perfused placenta culminates in substantially decreased fetal oxygenation and nutrient supply.&nbsp; Over the course of several weeks (as in this patient with no prenatal care in a month), fetal growth can rapidly decrease, resulting in a <strong>small-for-gestational-age infant</strong> (potentially 1-2 lb less than average birth weight).</p><p><strong>(Choice A)</strong>&nbsp; Neonatal hypoxic brain injury can occur with severe, acute decreases in placental perfusion or fetal oxygenation (eg, severe <a href=\"1056\">placental abruption</a>, shoulder dystocia) because the fetus has no time to adapt to lower oxygen levels.&nbsp; Because preeclampsia causes chronically low uteroplacental perfusion, over time the fetus adapts by preferentially shunting oxygenated blood from the body to the brain, thereby sparing brain injury.</p><p><strong>(Choices B and D)</strong>&nbsp; Intraventricular hemorrhage and neonatal respiratory distress syndrome are complications of prematurity (ie, &lt;37 weeks gestation).&nbsp; Preeclampsia is not an independent risk factor for either.</p><p><strong>(Choice C)</strong>&nbsp; Kernicterus, the neurologic sequelae of neonatal hyperbilirubinemia, most commonly is caused by neonatal hemolysis (eg, ABO or Rh[D] incompatibility).&nbsp; Preeclampsia can cause hemolysis and hyperbilirubinemia in the mother, but there is minimal transplacental bilirubin transfer to the fetus.</p><p><strong>(Choice F)</strong>&nbsp; Preeclampsia causes maternal platelet consumption and thrombocytopenia.&nbsp; It does not cause neonatal thrombocytopenia, which typically occurs due to immune-mediated thrombocytopenia.</p><p><strong>Educational objective:</strong><br>Preeclampsia with severe features increases the risk of fetal growth restriction (ie, small-for-gestational-age infant) due to uteroplacental insufficiency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hypoxic brain injury",
                    "choiceNumber": 1,
                    "correctTaken": 4902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraventricular hemorrhage",
                    "choiceNumber": 2,
                    "correctTaken": 885,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Kernicterus",
                    "choiceNumber": 3,
                    "correctTaken": 1360,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Respiratory distress syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 995,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Small for gestational age",
                    "choiceNumber": 5,
                    "correctTaken": 7936,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thrombocytopenia",
                    "choiceNumber": 6,
                    "correctTaken": 824,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28636133",
                    "mediaDataId": 0,
                    "title": "Association of chronic hypertension with birth of small-for-gestational-age neonate.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28636133",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28501274",
                    "mediaDataId": 0,
                    "title": "Impact of fetal growth on pregnancy outcomes in women with severe preeclampsia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28501274",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 101,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16902,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 101,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 14895,
            "questionIndex": 16318,
            "questionText": "<p>A 34-year-old woman, gravida 2 para 2, is evaluated on the postpartum floor for nausea and lightheadedness.&nbsp; The patient developed these symptoms when she tried to ambulate to the bathroom, forcing her to immediately lie down.&nbsp; Earlier today, she underwent a repeat cesarean delivery at 39 weeks gestation; she is taking scheduled NSAIDs for incisional pain.&nbsp; The patient is fatigued and feels like she can barely keep her eyes open.&nbsp; She has no chronic medical conditions and takes no daily medications.&nbsp; Blood pressure is 80/50 mm Hg, pulse is 124/min, and respirations are 18/min.&nbsp; The patient appears pale and has cold skin.&nbsp; The uterine fundus is firm at the umbilicus, and the abdomen is tender but has no increased bleeding from the incision site.&nbsp; On pelvic examination, there is minimal lochia and no clots.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This postpartum patient with hypotension, tachycardia, and signs of decreased end-organ perfusion (eg, fatigue, lightheadedness, cold skin) most likely has hypovolemic shock due to <strong>postpartum hemorrhage</strong>.&nbsp; Postpartum hemorrhage typically occurs within hours of delivery; uterine atony is the most common cause.&nbsp; Therefore, initial evaluation requires bimanual examination to assess for an enlarged, boggy uterus and heavy vaginal bleeding consistent with atony.</p><p>In contrast, post-cesarean delivery patients with hemorrhagic shock and <strong>no signs of uterine atony</strong> (such as this patient) most likely have <strong>intraabdominal bleeding</strong> from uterine artery injury.&nbsp; Because pregnancy increases uterine artery blood flow, an intrapartum <strong>uterine artery injury</strong> can lead to rapid and massive blood loss with subsequent hemodynamic instability.&nbsp; This patient&#39;s bleeding is most likely located in the retroperitoneum (ie, <strong>retroperitoneal hematoma</strong>), which is a rare but life-threatening cause of postpartum hemorrhage that typically presents with <strong>no incisional bleeding</strong> and <strong>minimal abdominal or back pain</strong>, as the retroperitoneum has a vast potential space for blood accumulation before built-up pressure causes peritoneal stretching and pain.</p><p><strong>Hemodynamically unstable</strong> patients with a suspected retroperitoneal hematoma <strong>require emergency laparotomy</strong>.</p><p><strong>(Choice A)</strong>&nbsp; A prolonged postoperative ileus or mild small bowel obstruction can be managed with antiemetics and serial examinations.&nbsp; These patients typically have vomiting and abdominal distension, which are not seen in this patient.&nbsp; In addition, postoperative gastrointestinal complications typically present several days to weeks after surgery unlike postpartum hemorrhage, which occurs within hours of delivery.</p><p><strong>(Choice B)</strong>&nbsp; CT scan of the abdomen and pelvis can confirm the diagnosis of a retroperitoneal hematoma but is only appropriate for hemodynamically stable patients.&nbsp; Stable patients may then undergo arterial embolization for control of bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Oxytocin infusion and <a href=\"24917\">fundal massage</a> are used to treat uterine atony, but this patient&#39;s fundus is firm and her lochia minimal, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Transvaginal ultrasound can diagnose postpartum hemorrhage due to a retained placenta; however, patients typically have heavy vaginal bleeding, which is not seen in this patient.</p><p><strong>Educational objective:</strong><br>Retroperitoneal hematomas may occur postpartum due to uterine artery injury, leading to massive blood loss and hemodynamic instability despite minimal abdominal pain and no obvious source of bleeding.&nbsp; Hemodynamically unstable patients with a suspected retroperitoneal hematoma require emergency laparotomy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12409,
            "topic": "Cesarean delivery",
            "titleId": 12409,
            "title": "Cesarean delivery",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiemetics and serial examinations",
                    "choiceNumber": 1,
                    "correctTaken": 1213,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen and pelvis",
                    "choiceNumber": 2,
                    "correctTaken": 3222,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergency laparotomy",
                    "choiceNumber": 3,
                    "correctTaken": 9584,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin infusion and fundal massage",
                    "choiceNumber": 4,
                    "correctTaken": 941,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 1651,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27651589",
                    "mediaDataId": 0,
                    "title": "Return to the operation theatre: an analysis of repeat surgeries in operative obstetrics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27651589",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22921276",
                    "mediaDataId": 0,
                    "title": "Risk factors for relaparotomy after cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22921276",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21417659",
                    "mediaDataId": 0,
                    "title": "Selective arterial embolisation: life-saving intervention in the management of retroperitoneal haematoma in obstetrics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21417659",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 103,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16611,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 103,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 13868,
            "questionIndex": 15262,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 30 weeks gestation comes to the office for a routine prenatal visit.&nbsp; For the past week, the patient has had increasing pruritus that has been most severe on her palms.&nbsp; She has tried using oatmeal baths and lotion, but the itching has continued.&nbsp; The patient also has had nausea and difficulty sleeping due to pruritus and increasing back pain.&nbsp; She takes diphenhydramine and acetaminophen nightly to help her sleep.&nbsp; The patient has chronic hypertension that has been well controlled during the pregnancy.&nbsp; Blood pressure is 138/86 mm Hg and pulse is 76/min.&nbsp; Fundal height is 30 cm.&nbsp; Fetal heart rate is 150/min.&nbsp; Multiple excoriations are noted on the abdomen and thighs.&nbsp; The remainder of the examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total protein</td><td style=\"vertical-align:middle;\">4.5 g/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">170 U/L (normal during pregnancy: 38-229)</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">66 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">74 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total bile acids</td><td style=\"vertical-align:middle;\">26 &micro;mol/L (normal: &lt;10)</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40285\" style=\"overflow-x:auto;\" tid=\"15384\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intrahepatic cholestasis of pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Development in 3rd trimester</li><li>Generalized pruritus</li><li>Pruritus worse on hands &amp; feet</li><li>No associated rash</li><li>Right upper quadrant pain</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory abnormalities</strong></p></td><td><ul><li>&#8593; Total bile acids (&#8805;10 &micro;mol/L)</li><li>&#8593; Liver transaminases (typically &lt;2&times; normal, rarely &gt;1,000 U/L)</li><li>&plusmn; &#8593; Total &amp; direct bilirubin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric risks</strong></p></td><td><ul><li>Intrauterine fetal demise</li><li>Preterm delivery</li><li>Meconium-stained amniotic fluid</li><li>Neonatal respiratory distress syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Ursodeoxycholic acid</li><li>Antihistamines</li><li>Delivery at 37 weeks gestation</li></ul></td></tr></tbody></table></div><p>This patient&#39;s pruritus that is most severe on the palms with no associated rash is consistent with <strong>intrahepatic cholestasis of pregnancy (ICP)</strong>, which typically occurs during the third trimester.&nbsp; ICP is likely due to increased estrogen and progesterone that cause hepatobiliary tract stasis and decreased bile excretion.&nbsp; This results in <strong>elevated total bile acids</strong> (&#8805;10 &micro;mol/L, diagnostic of ICP) and can cause a generalized, intractable <strong>pruritus that is worse on the palms and soles</strong>.&nbsp; Some patients have right upper quadrant pain and elevated aminotransferases; alkaline phosphatase is often elevated but is not specific for ICP because it is also produced by the placenta.</p><p>ICP does not increase the risk of maternal complications; however, due to transplacental passage of bile acids, it does increase the risk of fetal complications (eg, intrauterine fetal demise, meconium-stained amniotic fluid).&nbsp; For this reason, management includes both treatment of maternal pruritus and <strong>prevention of fetal complications</strong>.&nbsp; First-line treatment is with <strong>ursodeoxycholic acid</strong>, which relieves pruritus and may decrease obstetric complications.&nbsp; In addition, patients require regular fetal assessment (eg, nonstress test) and <strong>delivery at 37 weeks gestation</strong>.</p><p><strong>(Choices A and B)</strong>&nbsp; Emergency delivery and magnesium sulfate may be indicated in patients who have chronic hypertension with superimposed preeclampsia or acute fatty liver of pregnancy (AFLP).&nbsp; Superimposed preeclampsia presents with hypertension (systolic &#8805;140 mm Hg and/or diastolic &#8805;90 mm Hg) and may cause elevated aminotransferases (&#8805;2&times; upper limit of normal).&nbsp; In contrast, AFLP may present with hypertension but always causes elevated aminotransferases (usually 5-10&times; normal range).&nbsp; These diagnoses are unlikely because neither condition causes elevated total bile acids, and this patient is normotensive.</p><p><strong>(Choice C)</strong>&nbsp; N-acetylcysteine is used in the treatment of acetaminophen poisoning, which can present with elevated aminotransferases.&nbsp; However, patients typically have acute nausea and vomiting that develop into right upper quadrant pain and hepatomegaly; aspartate and alanine aminotransferase levels are usually &gt;1,000 U/L.</p><p><strong>(Choice D)</strong>&nbsp; Topical corticosteroids are used for polymorphic eruption of pregnancy (or pruritic urticarial papules and plaques of pregnancy), which causes pruritus and rash within the abdominal striae; the pruritus spreads centrifugally but spares the palms and soles.&nbsp; Topical corticosteroids do not relieve pruritus associated with ICP.</p><p><strong>Educational objective:</strong><br>Intrahepatic cholestasis of pregnancy presents in the third trimester with pruritus that is worse on the hands and feet with no associated rash.&nbsp; Diagnosis is confirmed by elevated total bile acids (&#8805;10 &micro;mol/L).&nbsp; Management includes ursodeoxycholic acid and delivery at 37 weeks gestation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 24239,
            "topic": "Dermatoses of pregnancy",
            "titleId": 24239,
            "title": "Dermatoses of pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Emergency delivery",
                    "choiceNumber": 1,
                    "correctTaken": 359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 2,
                    "correctTaken": 95,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "N-acetylcysteine",
                    "choiceNumber": 3,
                    "correctTaken": 111,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical corticosteroid",
                    "choiceNumber": 4,
                    "correctTaken": 178,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ursodeoxycholic acid",
                    "choiceNumber": 5,
                    "correctTaken": 4350,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "177",
                    "mediaDataId": 0,
                    "title": "Intrahepatic cholestasis of pregnancy",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30773280",
                    "mediaDataId": 0,
                    "title": "Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30773280",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26071912",
                    "mediaDataId": 0,
                    "title": "Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26071912",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 5093,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 78,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 2407,
            "questionIndex": 2407,
            "questionText": "<p>A 36-year-old woman, gravida 2 para 1, at 35 weeks gestation comes to the labor and delivery unit due to vaginal bleeding and constant back pain for the past hour.&nbsp; The patient has a history of chronic hypertension that has been well controlled with labetalol throughout the pregnancy.&nbsp; Prenatal laboratory tests and ultrasounds have been normal.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 104/70 mm Hg, and pulse is 118/min.&nbsp; Physical examination shows a smooth, firm, and distended uterus with a fundal height of 38 cm.&nbsp; Speculum examination reveals a small amount of bleeding and a closed cervix.&nbsp; The first 10 minutes of fetal monitoring show a baseline heart rate of 160/min, minimal variability, and 3 late decelerations.&nbsp; Uterine contractions are observed every 1-2 minutes.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"1056\" src=\"https://www.uworld.com/media/L16446.jpg\" ></p><p>This patient with vaginal bleeding; a firm, distended uterus; and fetal decelerations has <strong>abruptio placentae</strong>.&nbsp; Placental abruption occurs when maternal vessels rupture at the uteroplacental interface, causing premature separation of the placenta from the uterus.</p><p>A common risk factor is <strong>chronic hypertension</strong>.&nbsp; Maternal hypertension, regardless of well-controlled blood pressure, is associated with widespread <strong>endothelial dysfunction</strong>.&nbsp; This dysfunction impairs normal development of the spiral arteries that supply blood to the fetus and placenta; the result is abnormally high-resistance spiral arteries that lead to <strong>low placental perfusion</strong>, <strong>ischemia</strong>, and possible <strong>infarction</strong>, all of which increase the risk of abruptio placentae.&nbsp; In addition, chronic endothelial dysfunction <strong>increases vessel frailty</strong> and the risk of vessel rupture at the uteroplacental interface.&nbsp; Other risk factors for abruptio placentae include tobacco or cocaine use (due to placental ischemia) and abdominal trauma.</p><p>Although most patients with abruptio placentae have heavy <strong>vaginal bleeding</strong>, up to 20% have minimal or no bleeding because blood is concealed within the intrauterine cavity.&nbsp; These patients typically have <strong>focal pain</strong> (eg, back pain, suggesting posterior placental rupture), an abnormally <strong>distended uterus</strong> (eg, measuring 38 cm at 35 weeks gestation), and <strong>high-frequency contractions</strong> due to increasing intrauterine pressure and volume.&nbsp; As more of the placenta detaches, fetal hypoxia can occur, as evidenced by abnormalities on the fetal heart rate tracing (eg, late decelerations).</p><p><strong>(Choice B)</strong>&nbsp; Intraamniotic infection can cause abdominal pain; however, patients are typically febrile with fundal tenderness.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"4268\">Placenta previa</a>, placental implantation over the cervix, causes painless vaginal bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Preterm labor is contractions that cause cervical dilation at &lt;37 weeks gestation.&nbsp; Labor pain is typically intermittent because the uterus relaxes between contractions.&nbsp; In contrast, this patient has constant pain and a closed cervix.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"1057\">Uterine rupture</a> commonly causes abdominal pain, vaginal bleeding, and fetal heart rate abnormalities.&nbsp; However, patients typically have diminishing contractions and fetal parts palpable through the maternal abdominal wall.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"28587\">Vasa previa</a> can present with vaginal bleeding due to injury to fetal vessels overlying the cervix; however, the bleeding is typically painless.</p><p><strong>Educational objective:</strong><br>Abruptio placentae, premature placental detachment from the uterus prior to fetal delivery, is caused by maternal vessel rupture at the uteroplacental interface.&nbsp; Patients typically have acute pain, vaginal bleeding, and abnormalities on fetal heart rate tracing.&nbsp; Chronic hypertension, regardless of blood pressure control, is a risk factor due to underlying maternal endothelial dysfunction.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 11572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 2,
                    "correctTaken": 163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 3,
                    "correctTaken": 1315,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm labor",
                    "choiceNumber": 4,
                    "correctTaken": 1562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 5,
                    "correctTaken": 510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vasa previa",
                    "choiceNumber": 6,
                    "correctTaken": 1563,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21490793",
                    "mediaDataId": 0,
                    "title": "Is the perinatal outcome of placental abruption modified by clinical presentation?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21490793",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21241259",
                    "mediaDataId": 0,
                    "title": "Placental abruption: epidemiology, risk factors and consequences.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21241259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 105,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16685,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 105,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 10865,
            "questionIndex": 11998,
            "questionText": "<p>A 32-year-old woman, gravida 1 para 0, comes to the office for an initial prenatal visit after a positive home pregnancy test.&nbsp; The patient has had some nausea and breast tenderness but no abdominal cramping or vaginal bleeding.&nbsp; Her last menstrual period was 9 weeks ago; prior to conception she had regular, monthly menstrual cycles with 5 or 6 days of heavy bleeding.&nbsp; During the first 2 days of her menses, the patient had painful cramping, particularly after stopping her oral contraceptives last year.&nbsp; She has no chronic medical conditions, and her only medication is a daily prenatal vitamin.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Bimanual pelvic examination shows a 15-week-size, mobile uterus with an irregular contour.&nbsp; Urine pregnancy test is positive.&nbsp; Which of the following is the most likely cause of this patient&#39;s uterine size-date discrepancy?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"4394\" src=\"https://www.uworld.com/media/highresdefault/L28497.jpg\"  ></p><p>This <strong>pregnant</strong> patient has a <strong>uterine size-greater-than-date discrepancy</strong>: a 15 week-size uterus at 9 weeks gestation based on her last menstrual period (LMP).&nbsp; A size-greater-than-date discrepancy usually has an obstetric cause, such as incorrect dating (the most common cause), multiple gestation, polyhydramnios, or gestational trophoblastic disease (eg, hydatidiform mole).&nbsp; However, none of the above conditions would produce an <strong>irregular uterine contour</strong> in early pregnancy <strong>(Choices D, E, and G)</strong>.&nbsp; An abnormal uterus is more likely.&nbsp; In this patient with an irregular uterine contour and history of heavy menses, the most likely cause is <strong>leiomyomata uteri</strong> (uterine fibroids).</p><p>Leiomyomas are benign, uterine smooth muscle tumors and the most common pelvic tumor in women.&nbsp; Fibroids share some clinical features (eg, uterine enlargement, constipation) with pregnancy.&nbsp; Other signs and symptoms vary by fibroid size and location:</p><ul><li><p>Leiomyomas on the uterine surface (subserosal) and within the uterine wall (intramural) are most likely to cause an <strong>enlarged uterus</strong>, an <strong>irregular uterine contour</strong>, and bulk symptoms (eg, pelvic pressure, constipation).</p></li><li><p>Submucosal fibroids (located beneath the endometrium) can cause <strong>prolonged and/or heavy menstrual bleeding</strong> with painful cramping (ie, dysmenorrhea) in nonpregnant patients.</p></li></ul><p>This patient likely has all 3 fibroid types.&nbsp; Although most fibroids do not adversely affect pregnancy, having large or multiple fibroids can increase the risk of obstetric complications (eg, spontaneous abortion, preterm labor, postpartum hemorrhage) and the rate of cesarean delivery.</p><p><strong>(Choice A)</strong>&nbsp; Patients with <a href=\"4392\">adenomyosis</a> can have painful, heavy menstrual bleeding and an enlarged uterus.&nbsp; However, the uterine contour is normal because the proliferation of ectopic endometrial glands is contained within the uterine wall.</p><p><strong>(Choice B)</strong>&nbsp; An <a href=\"4710\">ectopic pregnancy</a> is typically tubal or adnexal in location and therefore unlikely to cause an enlarged uterus or affect the uterine contour.&nbsp; A palpable adnexal mass may be present.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"1139\">Endometriosis</a> can cause dysmenorrhea; however, endometrial implants are typically adnexal (ie, endometrioma), peritoneal, or rectovaginal and therefore unlikely to cause an enlarged uterus with an irregular contour.</p><p><strong>Educational objective:</strong><br>In pregnancy, leiomyomata uteri (uterine fibroids) can cause a uterine size-greater-than-date discrepancy and an irregular uterine contour.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adenomyosis",
                    "choiceNumber": 1,
                    "correctTaken": 602,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 72,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 3,
                    "correctTaken": 473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 4,
                    "correctTaken": 1955,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incorrect dating",
                    "choiceNumber": 5,
                    "correctTaken": 1828,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Leiomyomata uteri",
                    "choiceNumber": 6,
                    "correctTaken": 10286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple gestation",
                    "choiceNumber": 7,
                    "correctTaken": 1431,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24705132",
                    "mediaDataId": 0,
                    "title": "The impact of fibroid characteristics on pregnancy outcome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24705132",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 197,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16647,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 197,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 10879,
            "questionIndex": 12015,
            "questionText": "<p>A 36-year-old woman, gravida 1 para 0, at 38 weeks gestation comes to the hospital due to increased leakage of fluid.&nbsp; She reports spontaneous rupture of membranes approximately 48 hours earlier, and contractions started 12 hours after rupture.&nbsp; She reports intermittent vaginal spotting and regular fetal movement.&nbsp; The patient was attempting a home birth but came to the hospital because her cervix has been 6 cm dilated for the past 5 hours.&nbsp; Temperature is 39.4 C (103 F), blood pressure is 120/80 mm Hg, and pulse is 108/min.&nbsp; Digital examination reveals the cervix to be 6 cm dilated and 70% effaced, with the fetal vertex at 0 station.&nbsp; The fetal heart tracing is shown in the <a href=\"4567\">exhibit</a>.&nbsp; Which of the following is most likely responsible for the findings on this patient&#39;s fetal monitoring?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intraamniotic infection (chorioamnionitis)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prolonged rupture of membranes (&gt;18 hr)</li><li>Preterm prelabor rupture of membranes</li><li>Prolonged labor</li><li>Internal fetal/uterine monitoring devices</li><li>Repetitive vaginal examinations</li><li>Presence of genital tract pathogens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Maternal fever PLUS &ge;1 of the following:</p><ul><li>Fetal tachycardia (&gt;160/min)</li><li>Maternal leukocytosis</li><li>Purulent amniotic fluid</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Broad-spectrum antibiotics</li><li>Delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Maternal: postpartum hemorrhage, endometritis</li><li>Neonatal: preterm birth, pneumonia, encephalopathy</li></ul></td></tr></tbody></table></div><p>This patient has a <a href=\"4569\">fetal heart tracing</a> with moderate variability and <strong>fetal tachycardia</strong>, a sustained fetal baseline heart rate &gt;160/min.&nbsp; Common causes of fetal tachycardia include maternal infection, poorly controlled maternal hyperthyroidism, medication use (eg, terbutaline), and <a href=\"2483\">abruptio placentae</a>.&nbsp; This patient has an <strong>intraamniotic infection</strong> (chorioamnionitis) of the uterine decidua, placenta, amniotic fluid, membranes, and umbilical cord that results from migration of vaginal or enteric flora through the cervix into the uterine cavity.</p><p>In the setting of <strong>protracted or arrested labor</strong> (slow labor progression) and <strong>prolonged membrane rupture</strong> (&gt;18 hours), <strong>maternal fever</strong> suggests intraamniotic infection as the etiology of the fetal tachycardia.&nbsp; Additional clinical features of intraamniotic infection include maternal leukocytosis, purulent amniotic fluid, maternal tachycardia, and uterine fundal tenderness.&nbsp; Broad-spectrum antibiotics are administered to reduce the risk of neonatal (eg, sepsis, encephalopathy) and maternal (eg, postpartum hemorrhage, endometritis) morbidity.</p><p><strong>(Choice A)</strong>&nbsp; Fetal anemia typically presents with a <a href=\"27466\">sinusoidal fetal heart tracing</a>, a smooth, undulating waveform with no variability.&nbsp; This patient&#39;s tracing has moderate variability.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"2411\">Early decelerations</a> are shallow decreases in the fetal heart rate that occur as a mirror image with the uterine contraction.&nbsp; They are likely an autonomic response to alterations in intracranial pressure caused by fetal head compression during contractions.&nbsp; This fetal tracing has no early decelerations.</p><p><strong>(Choice C)</strong>&nbsp; Fetal sleep cycles are commonly associated with nonreactive non-stress tests (no accelerations), but they do not cause fetal tachycardia.</p><p><strong>(Choice E)</strong>&nbsp; Placental insufficiency causes late decelerations, which are smooth and subtle drops in the fetal heart rate following a contraction due to placental hypoperfusion during the contraction that results in transient fetal hypoxia.&nbsp; This fetal tracing has no late decelerations.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"2412\">Variable decelerations</a>, abrupt drops in the fetal heart rate of varying depth and duration, are likely due to compression of the umbilical cord causing transient fetal hypertension that triggers a parasympathetic response and slows the heart rate.&nbsp; Umbilical cord compression does not cause sustained fetal tachycardia.</p><p><strong>Educational objective:</strong><br>Intraamniotic infection, also known as chorioamnionitis, is a cause of fetal tachycardia (baseline heart rate &gt;160/min).&nbsp; Intraamniotic infection is caused by migration of vaginal or enteric flora through the cervix and is associated with prolonged rupture of membranes and a protracted labor course.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal anemia",
                    "choiceNumber": 1,
                    "correctTaken": 376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal head compression",
                    "choiceNumber": 2,
                    "correctTaken": 567,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal sleep cycle",
                    "choiceNumber": 3,
                    "correctTaken": 466,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 4,
                    "correctTaken": 13439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Umbilical cord compression",
                    "choiceNumber": 6,
                    "correctTaken": 1247,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "161",
                    "mediaDataId": 0,
                    "title": "Fetal heart rate tracings",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18757666",
                    "mediaDataId": 0,
                    "title": "The 2008 national institute of child health and human development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18757666",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 16738,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 77,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 26916,
            "questionIndex": 114817,
            "questionText": "<p>A 34-year-old woman, gravida 0 para 0, comes to the office for an infertility evaluation.&nbsp; The patient and her partner have been trying to conceive for the past 15 months without success.&nbsp; Her partner has no prior children from another relationship, and she has never been pregnant.&nbsp; The patient has no chronic medical conditions and has had no previous surgeries.&nbsp; Her only medication is a prenatal vitamin.&nbsp; The patient has regular menstrual cycles that occur every 30 days with 5 or 6 days of light to moderate bleeding.&nbsp; Her partner&#39;s semen analysis returned with no abnormality.&nbsp; Vital signs are normal.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination, including pelvic examination, is unremarkable.&nbsp; Hysterosalpingography is performed and results are shown in the <a href=\"3029\">exhibit</a>.&nbsp; If this patient becomes pregnant, she is most at risk for which of the following pregnancy-related complications?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3030\" src=\"https://www.uworld.com/media/highresdefault/L25900.png\"  ></p><p>Evaluation for <strong>female factor infertility</strong> often includes <strong>hysterosalpingography (HSG)</strong> to identify genital tract anomalies and <a href=\"49027\">fallopian tube patency</a>.&nbsp; This patient&#39;s HSG reveals 2 unfused uterine horns, findings consistent with either a bicornuate or a septate uterus, which are <a href=\"3032\">types</a> of <strong>congenital uterine anomalies</strong>.&nbsp; Those with uterine anomalies have distorted uterine cavities that can lead to <strong>adverse reproductive and obstetric outcomes</strong>, including the following:</p><ul><li><p>Spontaneous abortion:&nbsp; Congenital uterine anomalies are commonly associated with absent or abnormal vasculature and <strong>diminished uterine blood flow</strong>.&nbsp; Therefore, pregnancies experience <a href=\"55905\">decreased placental perfusion</a> and inadequate nutrition, which can cause fetal growth restriction or <strong>recurrent pregnancy loss</strong>.</p></li><li><p><strong>Preterm labor</strong>:&nbsp; Because it has 2 separate, <strong>smaller uterine cavities</strong>, a bicornuate or septate <strong>uterus cannot expand fully</strong> in volume to accommodate a full-term pregnancy.&nbsp; When the fetus becomes larger than the cavity, uterine overdistension may trigger preterm labor.&nbsp; Uterine anomalies may also adversely affect the structural integrity of the cervix, increasing the risk for cervical insufficiency and second-trimester pregnancy loss.</p></li></ul><p>Some congenital uterine anomalies, such as a septate uterus, can be surgically corrected to recreate a single, larger uterine cavity for improved obstetric outcomes.</p><p><strong>(Choice A)</strong>&nbsp; Congenital uterine anomalies do not increase the risk for multiple gestation pregnancies; they likely decrease the risk due to both insufficient uterine volume and vascularity to support &gt;1 gestation.</p><p><strong>(Choices B and E)</strong>&nbsp; Although placental perfusion can be diminished, congenital uterine anomalies do not affect the risk for other placentation abnormalities, such as <a href=\"2778\">placenta previa</a> and placenta accreta (a risk factor for <a href=\"4513\">uterine inversion</a>).&nbsp; The most common risk factor for these placental conditions is prior uterine scarring (ie, prior cesarean delivery).</p><p><strong>(Choice D)</strong>&nbsp; The primary cause of postpartum hemorrhage is uterine atony, in which the uterus distends with blood and stays boggy after delivery.&nbsp; Congenital uterine anomalies are associated with smaller uterine cavities, which are typically more inflexible and less likely to contribute to atony.</p><p><strong>Educational objective:</strong><br>Congenital uterine anomalies, which typically lead to separate, smaller uterine cavities, can increase the risk for preterm labor because the uterus cannot accommodate the size of a full-term pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12563,
            "topic": "Congenital uterine anomalies",
            "titleId": 12563,
            "title": "Congenital uterine anomalies",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Multiple gestation",
                    "choiceNumber": 1,
                    "correctTaken": 348,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 2,
                    "correctTaken": 664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm labor",
                    "choiceNumber": 3,
                    "correctTaken": 4085,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine atony",
                    "choiceNumber": 4,
                    "correctTaken": 180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine inversion",
                    "choiceNumber": 5,
                    "correctTaken": 150,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26768640",
                    "mediaDataId": 0,
                    "title": "Pregnancy and delivery in women with uterine malformations.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26768640",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 84,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 5427,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 84,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 3118,
            "questionIndex": 3118,
            "questionText": "<p>A 35-year-old woman, gravida 2 para 1, at 34 weeks gestation comes to the office to establish prenatal care.&nbsp; She recently moved but had routine prenatal care in another state, including normal first-trimester and anatomy ultrasounds.&nbsp; The patient never discussed delivery planning but would like to attempt a vaginal delivery, if possible.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; This pregnancy has been uncomplicated, and her only medications are a daily aspirin and prenatal vitamin.&nbsp; Blood pressure is 118/70 mm Hg.&nbsp; Fetal heart tones are 145/min and fundal height is 38 cm.&nbsp; Urine dipstick is negative for protein and glucose.&nbsp; An ultrasound is performed due to a uterine size/dates discrepancy.&nbsp; The ultrasound shows a posterior placenta, normal amniotic fluid volume, and a fetus in frank breech presentation with an estimated fetal weight at the 50th percentile for gestational age.&nbsp; On review of records, the patient had a classical cesarean delivery with an incision involving the contractile portion of the uterus at 25 weeks gestation due to eclampsia and fetal growth restriction.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"83471\" src=\"https://www.uworld.com/media/highresdefault/L113331.png\"  ></p><p>Patients with a <strong>breech presentation</strong>&mdash;a fetal malpresentation in which the <a href=\"16678\">buttocks</a> or <a href=\"16679\">feet</a> are the fetal parts closest to the maternal cervix&mdash;are typically managed with a scheduled cesarean delivery at term; this is because breech vaginal deliveries have a higher rate of complications (eg, umbilical cord prolapse, asphyxia) compared with cephalic vaginal deliveries.&nbsp; Those with breech presentation who do not want to have a scheduled cesarean delivery can sometimes be offered an <a href=\"1183\">external cephalic version (ECV)</a>, a procedure in which the fetus is manually rotated to cephalic presentation to allow for vaginal delivery.</p><p>However, a previous <strong>classical cesarean delivery</strong> (as in this patient) is a <strong>contraindication to vaginal delivery</strong>, regardless of fetal presentation, due to the risk of uterine rupture.&nbsp; A classical (vertical) uterine incision is typically performed at very early gestational ages when the underdeveloped lower uterine segment cannot accommodate a low-transverse (horizontal) incision; it involves a vertical incision through the upper contractile portion of the myometrium.&nbsp; Because this area generates high intrauterine pressure during labor, the myometrial scar is less likely to withstand the pressure caused by labor contractions.&nbsp; As a result, there is an increased risk of <a href=\"1057\">uterine rupture</a>, an obstetric emergency <strong>(Choices A and B)</strong>.&nbsp; In contrast, a low-transverse cesarean delivery involves the acontractile lower portion of the uterus; a scar in this area has a significantly lower risk of uterine rupture.</p><p>For patients with a prior classical cesarean delivery, ECV is not typically offered, and a repeat <strong>cesarean delivery</strong> should be recommended (regardless of whether the patient would like to attempt a vaginal delivery).&nbsp; Repeat cesarean&nbsp;delivery&nbsp;is typically performed between <strong>36-37 weeks gestation</strong> to decrease the risk of spontaneous labor and subsequent neonatal and maternal complications.&nbsp; Other contraindications to vaginal delivery include placenta previa and prior extensive uterine myomectomy.</p><p><strong>(Choice C)</strong>&nbsp; An ECV can cause contractions, fetal distress, and prelabor rupture of membranes, which require immediate delivery.&nbsp; Therefore, the procedure is performed at &#8805;37 weeks gestation to decrease prematurity risks if delivery is required.&nbsp; However, because this patient has a contraindication to vaginal delivery (prior classical cesarean delivery), she is not a candidate for an ECV.</p><p><strong>(Choice E)</strong>&nbsp; This patient will have a cesarean delivery regardless of fetal presentation; a repeat ultrasound to reevaluate presentation is not indicated because it does not change the mode of delivery.</p><p><strong>Educational objective:</strong><br>Patients with breech presentation typically are offered an external cephalic version (ECV), in which the fetus is manually rotated to a cephalic presentation.&nbsp; In contrast, in patients with breech presentation and contraindications to vaginal delivery (eg, prior classical cesarean delivery, placenta previa), ECV is not recommended, and a cesarean delivery is performed.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Await spontaneous labor and perform internal podalic version",
                    "choiceNumber": 1,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induce labor for breech vaginal delivery at 40 weeks gestation",
                    "choiceNumber": 2,
                    "correctTaken": 19,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform external cephalic version at 36 weeks gestation",
                    "choiceNumber": 3,
                    "correctTaken": 425,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend a cesarean delivery at 37 weeks gestation",
                    "choiceNumber": 4,
                    "correctTaken": 3286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat ultrasound in 2 weeks to determine mode of delivery",
                    "choiceNumber": 5,
                    "correctTaken": 1167,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22757729",
                    "mediaDataId": 0,
                    "title": "Vaginal birth after cesarean and trial of labor after cesarean: what should we be recommending relative to maternal risk:benefit?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22757729",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23076883",
                    "mediaDataId": 0,
                    "title": "External cephalic version for breech presentation at term.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23076883",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32332415",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 221: external cephalic version.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32332415",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 93,
            "notes": null,
            "peopleTaken": 5058,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 141,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 13329,
            "questionIndex": 14703,
            "questionText": "<p>A 24-year-old woman, gravida 2 para 0 aborta 1, at 26 weeks gestation comes to the office for an initial prenatal visit.&nbsp; Prior to this, the patient&#39;s only prenatal care was a visit to the emergency department due to 2 days of persistent vomiting.&nbsp; At that time, a first trimester ultrasound was performed and was consistent with gestational age.&nbsp; Her previous pregnancy was a spontaneous abortion at 8 weeks gestation.&nbsp; Blood pressure is 120/70 mm Hg and pulse is 72/min.&nbsp; Fundal height is 32 cm.&nbsp; Maternal blood type is O, Rh negative.&nbsp; Indirect Coombs test is negative.&nbsp; Transabdominal ultrasound shows a female fetus with a biparietal diameter and head circumference that are consistent with 26 weeks gestation.&nbsp; Abdominal circumference measures at 34 weeks gestation.&nbsp; Fetal heart rate is 180/min.&nbsp; A pericardial effusion, bilateral pleural effusions, and polyhydramnios are noted in the fetus.&nbsp; Which of the following factors most likely contributed to this fetal presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T49920\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Fetal hydrops</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8593; cardiac output demand causing heart failure</li><li>&#8593; fluid movement into interstitial spaces (third spacing)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Pericardial effusion</li><li>Pleural effusion</li><li>Ascites</li><li>Skin edema</li><li>Placental edema</li><li>Polyhydramnios</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Immune<ul style=\"list-style-type:circle;\"><li>Rh(D) alloimmunization</li></ul></li><li>Nonimmune<ul style=\"list-style-type:circle;\"><li>Parvovirus B19 infection</li><li>Fetal aneuploidy</li><li>Cardiovascular abnormalities</li><li>Thalassemia (eg, hemoglobin Barts)</li></ul></li></ul></td></tr></tbody></table></div><p>This patient&#39;s fetus has <strong>fetal hydrops</strong> (<a href=\"23610\">hydrops fetalis</a>), an excessive fluid accumulation in the interstitium (eg, <strong>pericardial</strong> and <strong>pleural effusions</strong>) that is due to high-output heart failure from either immune or nonimmune etiologies.&nbsp; Rh(D) alloimmunization is the most common etiology of immune fetal hydrops; in contrast, <strong>maternal parvovirus B19 infection</strong> causes nonimmune fetal hydrops and is likely the reason for this patient&#39;s presentation.</p><p>Parvovirus B19 infection in adults can be asymptomatic (or associated with nonspecific flulike symptoms or arthralgias); however, in <a href=\"45503\">children</a>, it typically presents with a <strong>slapped-cheek rash</strong> that follows nonspecific prodromal symptoms (corresponding with viremia).&nbsp; The virus is&nbsp;transmitted&nbsp;via respiratory droplets.&nbsp; Pregnant women should avoid infected individuals because the virus can cross the placenta and have devastating fetal consequences.</p><p>Parvovirus B19 is highly cytotoxic to fetal red blood cell precursors, which can cause <strong>severe fetal anemia</strong> and result in <strong>increased cardiac output demand</strong> (as evidenced by fetal tachycardia with a fetal heart rate &gt;160/min).&nbsp; When cardiac output can no longer compensate for worsening fetal anemia and hypoxemia, fetuses develop <strong>high-output heart failure</strong> and its sequalae: effusions, ascites (eg, enlarged abdominal circumference), and polyhydramnios.&nbsp; Fetal hydrops has a high risk of fetal demise, and affected patients require serial ultrasounds and possible intrauterine transfusion.</p><p><strong>(Choice B)</strong>&nbsp; Inadequate maternal folate supplementation increases the risk for fetal neural tube defects (eg, spina bifida, meningocele).&nbsp; It does not cause fetal hydrops.</p><p><strong>(Choice C)</strong>&nbsp; Lack of anti-D immune globulin after delivery of an Rh(D)-positive infant can lead to <a href=\"1151\">Rh(D) alloimmunization</a> in Rh(D)-negative mothers.&nbsp; In future pregnancies, maternal anti-D antibodies attack Rh(D)-positive fetal erythrocytes, causing immune fetal hydrops.&nbsp; Although this patient is Rh(D)-negative, her antibody screen is negative, making this diagnosis unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Maternal rubella vaccination prevents congenital rubella syndrome, which is associated with fetal growth restriction and possible microcephaly.&nbsp; It does not present as fetal hydrops.</p><p><strong>(Choice E)</strong>&nbsp; Travel to tropical, mosquito-infested regions increases the risk of maternal Zika virus infection, which crosses the placenta and impairs fetal brain development.&nbsp; Affected fetuses may have microcephaly, ventriculomegaly, or intracranial calcifications on ultrasound.&nbsp; This patient&#39;s fetal biparietal diameter and head circumference are normal.</p><p><strong>Educational objective:</strong><br>Parvovirus B19 infection in pregnancy can cause nonimmune fetal hydrops, or excessive fluid accumulation in the interstitium (eg, pericardial or pleural effusions, ascites).&nbsp; Parvovirus B19 infection may be asymptomatic in adults but is commonly acquired by respiratory transmission from young children, who typically have a slapped-cheek facial rash that follows nonspecific prodromal symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14178,
            "topic": "Fetal hydrops",
            "titleId": 14178,
            "title": "Fetal hydrops",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Exposure to child with a slapped-cheek rash",
                    "choiceNumber": 1,
                    "correctTaken": 8976,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate maternal folate supplementation",
                    "choiceNumber": 2,
                    "correctTaken": 1049,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lack of Rh(D) immunization in prior pregnancy",
                    "choiceNumber": 3,
                    "correctTaken": 4408,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonadherence to vaccination schedule",
                    "choiceNumber": 4,
                    "correctTaken": 1444,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Travel to a tropical, mosquito-infested region",
                    "choiceNumber": 5,
                    "correctTaken": 816,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25557883",
                    "mediaDataId": 0,
                    "title": "Society for Maternal-Fetal Medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25557883",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25712632",
                    "mediaDataId": 0,
                    "title": "Etiology of nonimmune hydrops fetalis: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25712632",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 176,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16693,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 176,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 4781,
            "questionIndex": 4781,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p><strong>Item 1 of 2</strong><br>A 35-year-old woman, gravida 2 para 1, at 31 weeks gestation comes to the office with severe heartburn and right upper quadrant pain.&nbsp; She has experienced several episodes of nausea and vomiting this morning.&nbsp; The patient has had gastroesophageal reflux disease throughout the pregnancy, but the symptoms have rapidly become much worse.&nbsp; During her visit last week, she was fatigued, and her blood pressure was 130/80 mm Hg.&nbsp; Current blood pressure is 160/90 mm Hg and pulse is 86/min.&nbsp; BMI is 42 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows extreme tenderness to palpation in the midline and right upper quadrant of the abdomen but absence of peritoneal signs.&nbsp; Fetal heart tones are 130/min using Doppler ultrasound.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Hemoglobin</td><td>9.7 g/dL</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Platelets</td><td>80,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Leukocytes</td><td>8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Total protein</td><td>6 g/dL</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Albumin</td><td>2.6 g/dL</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Total bilirubin</td><td>2.2 mg/dL</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Direct bilirubin</td><td>0.5 mg/dL</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Alkaline phosphatase</td><td>170 U/L</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td>112 U/L</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td>124 U/L</td></tr><tr><td style=\"padding-left:2em; vertical-align:middle;\">Lipase</td><td>80 U/L (normal: &lt;160)</td></tr></tbody></table><p>Urine dipstick shows 2+ protein.&nbsp; Which of the following is the most likely cause of this patient&#39;s upper abdominal pain?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32701\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>HELLP syndrome*</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Nausea/vomiting</li><li>Right upper quadrant pain</li><li>Headache</li><li>Visual changes</li><li>Hypertension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory abnormalities</strong></p></td><td><ul><li>Microangiopathic hemolytic anemia</li><li>Elevated liver enzymes</li><li>Thrombocytopenia</li><li>&plusmn; Proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Delivery</li><li>Magnesium sulfate for seizure prophylaxis</li><li>Antihypertensives (eg, hydralazine)&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Abruptio placentae</li><li>Subcapsular liver hematoma</li><li>Acute renal failure</li><li>Pulmonary edema</li><li>Disseminated intravascular coagulation</li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.05in;\">*HELLP (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelet count).</p></td></tr></tbody></table></div><p>This pregnant patient with hypertension and right upper quadrant pain likely has <strong>preeclampsia with severe features</strong> (ie, new hypertension at &#8805;20 weeks gestation with signs of end-organ damage) and/or <strong>HELLP</strong> (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelets) <strong>syndrome</strong>.</p><p>These disorders likely represent a spectrum of disease causing maternal endothelial dysfunction (eg, <strong>hypertension</strong>, vasospasm).&nbsp; HELLP syndrome also causes platelet overactivation (ie, <strong>thrombocytopenia</strong>) and <strong>microangiopathic hemolytic anemia</strong> (ie, anemia with elevated indirect bilirubin) due to the deposition of platelet-fibrin microthrombi within capillaries.</p><p>The liver is commonly affected in HELLP syndrome.&nbsp; Microthrombi deposition in the hepatic portal system results in decreased hepatic perfusion, <strong>liver ischemia</strong>, and hepatocellular injury (eg, nausea/vomiting, right upper quadrant pain, <strong>elevated transaminases</strong>).&nbsp; The gradual <strong>distension of the hepatic [Glisson] capsule</strong> causes the classic presentation of worsening right upper quadrant pain without associated peritoneal signs.&nbsp; Severe cases may progress to liver necrosis and hemorrhage, resulting in a subcapsular hematoma (ie, <a href=\"39850\">blood pooling</a> beneath the hepatic capsule).</p><p><strong>(Choice A)</strong>&nbsp; Obstruction of the cystic duct (ie, cholelithiasis) may cause right upper quadrant pain and elevated liver transaminases; however, patients typically have elevated direct (ie, conjugated) bilirubin levels.&nbsp; There is no association with thrombocytopenia or hypertension.</p><p><strong>(Choice C)</strong>&nbsp; Acute fatty liver of pregnancy (AFLP) and HELLP syndrome share many features, including hypertension, right upper quadrant pain, and elevated transaminases.&nbsp; In contrast to HELLP syndrome, which causes indirect hepatocellular injury due to decreased liver perfusion, AFLP causes fulminant liver failure due to complete fatty infiltration of hepatocytes.&nbsp; Therefore, patients with AFLP typically have jaundice, encephalopathy, coagulopathy, and profound hypoglycemia.</p><p><strong>(Choice D)</strong>&nbsp; Lipase and leukocyte count are normal in this patient, making the diagnosis of pancreatitis less likely.&nbsp; In addition, pain associated with pancreatitis is typically midline and radiates to the back.</p><p><strong>(Choice E)</strong>&nbsp; Patients with peptic ulcer perforation can have right upper quadrant pain; however, they typically have peritoneal signs (eg, abdominal rigidity, rebound/guarding) due to intraperitoneal spillage of caustic gastric acid.</p><p><strong>(Choice F)</strong>&nbsp; Hepatic adenomas are benign liver tumors associated with elevated estrogen (eg, pregnancy, oral contraceptive use).&nbsp; Rupture leads to brisk intraabdominal bleeding, a possible palpable liver mass, and hemodynamic instability (eg, hypotension, tachycardia).</p><p><strong>Educational objective:</strong><br>HELLP (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, and <strong>L</strong>ow <strong>P</strong>latelets) syndrome can present during pregnancy with worsening right upper quadrant pain due to gradual distension of the hepatic (Glisson) capsule.&nbsp; Patients may have associated hypertension and proteinuria.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 7028,
            "topic": "HELLP syndrome",
            "titleId": 7028,
            "title": "HELLP syndrome",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 4781,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cystic duct obstruction",
                    "choiceNumber": 1,
                    "correctTaken": 2418,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Distension of the liver capsule",
                    "choiceNumber": 2,
                    "correctTaken": 10904,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fatty infiltration of the liver",
                    "choiceNumber": 3,
                    "correctTaken": 3681,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pancreatic inflammation",
                    "choiceNumber": 4,
                    "correctTaken": 141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peptic ulcer perforation",
                    "choiceNumber": 5,
                    "correctTaken": 391,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rupture of a hepatic adenoma",
                    "choiceNumber": 6,
                    "correctTaken": 478,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27535735",
                    "mediaDataId": 0,
                    "title": "HELLP syndrome: a diagnostic conundrum with severe complications.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27535735",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24428400",
                    "mediaDataId": 0,
                    "title": "Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24428400",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 213,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 18013,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 213,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 4782,
            "questionIndex": 4782,
            "questionText": "<p><strong>Item 2 of 2</strong><br>The patient is admitted to the hospital, and an intravenous line and urinary catheter are placed.&nbsp; She receives corticosteroids to accelerate fetal lung maturity and magnesium sulfate for fetal neuroprotection.&nbsp; Three hours later, the patient develops dyspnea and has a drop in arterial oxygen saturation.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 150/80 mm Hg, pulse is 112/min, and respirations are 24/min.&nbsp; Pulse oximetry is 91% on room air.&nbsp; Examination shows bibasilar crackles and use of accessory muscles for breathing.&nbsp; Heart sounds are tachycardic and without murmur.&nbsp; There is 3+ pitting edema of the lower extremities, and deep tendon reflexes are 2+ bilaterally.&nbsp; The remainder of the examination is normal.&nbsp; Urine output is 60 mL/hr.&nbsp; What is the most likely cause of this patient&#39;s respiratory symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7285\" src=\"https://www.uworld.com/media/L17454.png\" ></p><p>This patient&#39;s dyspnea, hypoxia, and bibasilar crackles on examination are most likely due to <strong>acute pulmonary edema</strong>, a life-threatening complication of preeclampsia with severe features.&nbsp; Patients with preeclampsia typically have <strong>generalized arterial vasospasm</strong>, leading to <strong>increased systemic vascular resistance</strong> and <strong>high cardiac afterload</strong>.&nbsp; In response, the heart becomes hyperdynamic to attempt to overcome the systemic hypertension.&nbsp; This causes increased pulmonary capillary pressure, which drives fluid from the capillaries into the interstitium.</p><p>Preeclampsia with severe features predisposes to acute pulmonary edema because it causes endothelial damage, leading to <strong>increased capillary permeability</strong>.&nbsp; This increased permeability promotes decreased serum albumin levels and decreased capillary oncotic pressure that enables third spacing (eg, peripheral pitting edema).&nbsp; In addition, normal diuresis is impeded due to <strong>decreased renal function</strong>.</p><p>Management includes supplemental oxygen, fluid restriction, and diuretic medications in severe cases.&nbsp; Fluid restriction and diuretic medications are used with caution because patients have overall decreased plasma volume (due to third spacing) and aggressive treatment may compromise placental perfusion and fetal wellbeing.</p><p><strong>(Choice A)</strong>&nbsp; Amniotic fluid embolism, caused by amniotic fluid entering the maternal circulation, can cause sudden hypoxemic respiratory failure.&nbsp; However, patients typically develop circulatory collapse with severe hypotension, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; Bronchospasm may cause dyspnea and hypoxemia, but it usually causes wheezing instead of bibasilar crackles.</p><p><strong>(Choice C)</strong>&nbsp; Excessive magnesium sulfate can cause neuromuscular depression, resulting in decreased respiratory effort/apnea, muscle paralysis, and somnolence.&nbsp; Unlike this patient, those with magnesium sulfate toxicity typically have decreased deep tendon reflexes and decreased respiratory effort.</p><p><strong>(Choice D)</strong>&nbsp; Peripartum cardiomyopathy can cause left ventricular failure and acute pulmonary edema with bibasilar lung crackles.&nbsp; However, patients typically have an S3 and murmur (ie, mitral regurgitation) and elevated jugular venous pressure.</p><p><strong>(Choice F)</strong>&nbsp; The risk for pulmonary embolus is increased peripartum due to the prothrombotic effects of estrogen.&nbsp; Although pulmonary embolism can cause tachycardia, tachypnea, and hypoxia, it does not typically cause acute bibasilar crackles and is not usually associated with pitting edema.</p><p><strong>Educational objective:</strong><br>Pulmonary edema is a life-threatening complication of preeclampsia with severe features.&nbsp; It is caused by increased systemic vascular resistance, capillary permeability, and pulmonary capillary hydrostatic pressure in addition to decreased serum albumin levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 4781,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniotic fluid embolism",
                    "choiceNumber": 1,
                    "correctTaken": 1376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bronchospasm",
                    "choiceNumber": 2,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate toxicity",
                    "choiceNumber": 3,
                    "correctTaken": 2470,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripartum cardiomyopathy",
                    "choiceNumber": 4,
                    "correctTaken": 1133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary edema",
                    "choiceNumber": 5,
                    "correctTaken": 10681,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary embolus",
                    "choiceNumber": 6,
                    "correctTaken": 2187,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29995818",
                    "mediaDataId": 0,
                    "title": "Acute pulmonary edema in an obstetric intensive care unit: a case series study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29995818",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23383864",
                    "mediaDataId": 0,
                    "title": "An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23383864",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 18009,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 57,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 15740,
            "questionIndex": 17177,
            "questionText": "<p>A 19-year-old woman, gravida 2 para 1, at 38 weeks gestation comes to the emergency department due to severe abdominal pain and vaginal bleeding.&nbsp; The patient had an ultrasound at 8 weeks gestation for vaginal spotting but has not otherwise received prenatal care this pregnancy.&nbsp; Her prior pregnancy two and a half years ago ended in a classical cesarean delivery at 24 weeks gestation for placental abruption.&nbsp; The patient smokes a pack of cigarettes daily and uses cocaine multiple times a week.&nbsp; Blood pressure is 90/60 mm Hg and pulse is 130/min.&nbsp; The abdomen is tender and has an irregular mass; no contractions are palpated.&nbsp; Bright red blood is noted on the perineal pad.&nbsp; Fetal heart tracing shows multiple prolonged decelerations to 100/min.&nbsp; Which of the following risk factors most likely contributed to this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32470\"><table class=\"table-default-style\" style=\"width:64.44%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Uterine rupture </strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Risk factors </strong></p></td><td><ul><li>Prior uterine surgery (eg, cesarean delivery, myomectomy)&nbsp;</li><li>Induction of labor/prolonged labor</li><li>Congenital uterine anomalies</li><li>Fetal macrosomia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Vaginal bleeding</li><li>Intraabdominal bleeding (hypotension, tachycardia)</li><li>Fetal heart decelerations</li><li>Loss of fetal station</li><li>Palpable fetal parts on abdominal examination</li><li>Loss of intrauterine pressure</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management&nbsp; </strong></p></td><td><ul><li>Laparotomy for delivery &amp; uterine repair&nbsp;</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation is most consistent with&nbsp;<strong>uterine rupture</strong>, a full-thickness disruption of the uterine wall.&nbsp; <a href=\"1057\">Uterine rupture</a>&nbsp;can present with severe, <strong>sudden-onset abdominal pain&nbsp;</strong>and vaginal bleeding; patients&nbsp;may have a <strong>palpable, irregular abdominal mass</strong> (ie, protruding fetal parts) and <strong>fetal decelerations</strong> due to fetal hypoxia and cord compression.&nbsp; Additional findings may include loss of fetal station and change in contraction pattern (eg, decreased uterine tone).&nbsp; Uterine rupture is an obstetric emergency because of the high risk of fetal demise and maternal hemorrhagic shock, as in this patient.</p><p>A significant <strong>risk factor</strong> for uterine rupture is <strong>prior uterine surgery</strong>, particularly a <strong>prior classical cesarean delivery</strong> because it creates a scar in the upper uterus (ie, near the fundus).&nbsp; The myometrium in the upper uterus is thick and contracts forcefully during labor.&nbsp; In patients with a prior classical cesarean delivery, the <a href=\"27766\">inelastic scar</a> may not withstand increasing uterine distension or labor contractions, resulting in uterine rupture.&nbsp; Treatment of uterine rupture is with emergent laparotomy and cesarean delivery.</p><p><strong>(Choice A)</strong>&nbsp; First-trimester bleeding can occur due to a <a href=\"8975\">subchorionic hematoma</a>, in which the chorion partially detaches from the uterus due to bleeding.&nbsp; Although this increases the risk of early pregnancy loss, it does not increase the risk of uterine rupture.</p><p><strong>(Choice B)</strong>&nbsp; Tobacco and cocaine use increases the risk of <a href=\"1113\">abruptio placentae</a> via vasoconstriction, resulting in placental ischemia, infarction, and premature placental separation from the uterus.&nbsp; Although abruptio placentae can cause abdominal pain, vaginal bleeding, and fetal bradycardia, it is not associated with an irregular abdominal mass.&nbsp; In addition, neither tobacco nor cocaine increases the risk of uterine rupture.</p><p><strong>(Choice C)</strong>&nbsp; A short interpregnancy interval (eg, &lt;6-18 months from last delivery) may increase the risk of uterine rupture due to insufficient time for uterine healing in patients who underwent cesarean delivery.&nbsp; This patient&#39;s last delivery was two and a half years ago, making this a less likely risk factor.</p><p><strong>(Choice D)</strong>&nbsp; Maternal age &#8805;35 may increase the risk of uterine rupture.&nbsp; This patient is age 19.</p><p><strong>Educational objective:</strong><br>Prior uterine surgery, particularly prior classical cesarean delivery, is a significant risk factor for uterine rupture, which can present with sudden-onset abdominal pain, vaginal bleeding, fetal decelerations, and an irregular abdominal mass (ie, protruding fetal parts).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4377,
            "topic": "Uterine rupture",
            "titleId": 4377,
            "title": "Uterine rupture",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "First-trimester bleeding",
                    "choiceNumber": 1,
                    "correctTaken": 82,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Illicit substance use",
                    "choiceNumber": 2,
                    "correctTaken": 8987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interpregnancy interval",
                    "choiceNumber": 3,
                    "correctTaken": 33,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal age",
                    "choiceNumber": 4,
                    "correctTaken": 46,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior uterine surgery",
                    "choiceNumber": 5,
                    "correctTaken": 7543,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681543",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 205: vaginal birth after cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681543",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21962624",
                    "mediaDataId": 0,
                    "title": "Optimal timing and mode of delivery after cesarean with previous classical incision or myomectomy: a review of the data.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21962624",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 60,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16691,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 60,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 13377,
            "questionIndex": 14755,
            "questionText": "<p>A 23-year-old woman, gravida 1 para 1, is evaluated on the postpartum floor due to increased perineal pain.&nbsp; The patient underwent a spontaneous vaginal delivery 8 hours ago after pushing for 3 hours.&nbsp; She had a second-degree perineal laceration repaired immediately after delivery.&nbsp; For the past 30 minutes, the patient has had increasing perineal pain, particularly with voiding.&nbsp; Temperature is 37.4 C (99.3 F), blood pressure is 132/86 mm Hg, and pulse is 90/min.&nbsp; On abdominal examination, there is no rebound or guarding and the uterus is firm and palpable below the umbilicus.&nbsp; The patient&#39;s pad contains a small amount of dark red blood, and no clots are expressed with uterine massage.&nbsp; The perineum and labia majora are edematous.&nbsp; The laceration repair appears intact with no purulent drainage but is tender to palpation.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"24036\" src=\"https://www.uworld.com/media/L45837.jpg\" ></p><p>During vaginal delivery, constant, increased pressure (eg, fetal head, maternal pushing) on maternal tissues causes vaginal, labial, and perineal edema.&nbsp; The vagina has increased elasticity to accommodate the fetal head, but other structures, such as the perineum, are less elastic and more likely to lacerate.&nbsp; Therefore, perineal lacerations are common after vaginal delivery, particularly in a primigravidas.</p><p>Perineal lacerations are classified based on depth.&nbsp; This patient has a <strong>second-degree perineal laceration</strong>, which disrupts the vaginal mucosa, perineal skin, and perineal body (ie, bulbocavernosus muscle).&nbsp; Second-degree perineal lacerations typically have no long-term sequelae because they heal quickly (due to high vascularity of vaginal tissue) and do not cause extensive muscle damage.&nbsp; This contrasts with more extensive lacerations, which disrupt the anal sphincter muscles (third-degree) and rectal mucosa (fourth-degree) and can lead to anal or fecal incontinence.</p><p>Although second-degree perineal lacerations heal quickly, patients in the <strong>immediate postpartum period</strong> often have <strong>localized pain</strong>, particularly with voiding (due to the proximity of the laceration to the urethra), and <strong>perineal edema</strong>.&nbsp; This pain is normal (ie, not a sign of infection) and requires only <strong>supportive care</strong> with nonsteroidal anti-inflammatory drugs and sitz baths.</p><p><strong>(Choices A, D, and E)</strong>&nbsp; In contrast to this patient&#39;s second-degree perineal laceration, infected perineal lacerations typically present with fever, wound breakdown (ie, nonintact repair), and purulent drainage.&nbsp; Patients with infected perineal lacerations require antibiotic therapy, suture removal, and surgical debridement.</p><p><strong>(Choice B)</strong>&nbsp; Exploratory laparotomy is indicated for an acute abdomen.&nbsp; This patient has normal vital signs, a firm uterine fundus (ie, no atony), a benign abdominal examination (eg, no rebound or guarding), and minimal vaginal bleeding.</p><p><strong>Educational objective:</strong><br>Perineal lacerations are common after vaginal delivery and typically cause perineal edema and pain with urination.&nbsp; Uncomplicated perineal lacerations (eg, no fever or purulence) are managed conservatively (eg, nonsteroidal anti-inflammatory drugs, sitz baths).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23383,
            "topic": "Postpartum complication",
            "titleId": 23383,
            "title": "Postpartum complication",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Broad-spectrum antibiotic therapy",
                    "choiceNumber": 1,
                    "correctTaken": 1104,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exploratory laparotomy",
                    "choiceNumber": 2,
                    "correctTaken": 182,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonsteroidal anti-inflammatory drugs and supportive care only",
                    "choiceNumber": 3,
                    "correctTaken": 13653,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Removal of suture",
                    "choiceNumber": 4,
                    "correctTaken": 1467,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgical perineal debridement",
                    "choiceNumber": 5,
                    "correctTaken": 558,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "175",
                    "mediaDataId": 0,
                    "title": "Perineal lacerations",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29683911",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 736: optimizing postpartum care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29683911",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27412362",
                    "mediaDataId": 0,
                    "title": "Oral nonsteroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27412362",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16964,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 124,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 14812,
            "questionIndex": 16235,
            "questionText": "<p>A 27-year-old woman, gravida 2 para 1, at 10 weeks gestation comes to the office for an initial prenatal visit.&nbsp; The patient has had no cramping or vaginal bleeding.&nbsp; She was not expecting this pregnancy because she had an uncomplicated term vaginal delivery 6 months ago and breastfed for the first 4 months postpartum.&nbsp; She is taking a daily prenatal vitamin and has no chronic medical conditions.&nbsp; Blood pressure is 126/80 mm Hg and pulse is 76/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The abdomen is soft, nontender, and nondistended.&nbsp; Pelvic ultrasound reveals a singleton intrauterine pregnancy at 10 weeks gestation with a fetal heart rate of 165/min.&nbsp; Hemoglobin is 10.4 g/dL.&nbsp; This patient is at increased risk for which of the following pregnancy-related complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T49594\"><table class=\"table-default-style table-header-footer-style\" style=\"width:67.88%\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.2in;\"><strong>Short interpregnancy interval</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>&lt;6-18 months from delivery to next pregnancy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Maternal anemia</li><li>PPROM</li><li>Preterm delivery</li><li>Low birth weight</li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:-.05in;\"><strong>PPROM</strong> = preterm prelabor rupture of membranes.</p></td></tr></tbody></table></div><p>Pregnancy, delivery, and the postpartum period place increased physical and metabolic demands on women in order to develop and provide nutrition for the fetus and newborn.&nbsp; During pregnancy, maternal folate and iron are depleted for fetal development, and the resulting <strong>maternal anemia</strong> is exacerbated by normal blood loss during delivery (eg, up to 10%-20% of blood volume).&nbsp; In breastfeeding women, continued nutritional demands from the newborn prevent repletion of normal folate and iron stores, resulting in prolonged anemia (as seen in this patient).</p><p>Due to these increased demands, women with <strong>short interpregnancy intervals</strong> (eg, &lt;6-18 months between delivery and the next pregnancy) have an <strong>increased risk of pregnancy complications</strong> including low birthweight, preterm labor, and <strong>preterm prelabor rupture of membranes</strong> (possibly due to persistent genital tract inflammation).&nbsp; Therefore, appropriate pregnancy timing with interval contraception (eg, progestin-containing intrauterine device) is recommended for adequate maternal recovery and optimization for future pregnancies.</p><p><strong>(Choice A)</strong>&nbsp; Risk of gestational diabetes mellitus is increased with obesity, certain medical conditions (eg, polycystic ovary syndrome), and prior gestational diabetes mellitus, which are not seen in this patient.&nbsp; Risk is not increased by a short interpregnancy interval.</p><p><strong>(Choice B)</strong>&nbsp; Short interpregnancy intervals increase risk of preterm (not postterm) delivery.&nbsp; Risk factors for postterm pregnancies include nulliparity and prior postterm pregnancy.</p><p><strong>(Choice C)</strong>&nbsp; Risk of preeclampsia is increased by prior preeclampsia, comorbid medical conditions (eg, chronic hypertension, diabetes mellitus), nulliparity, and long interpregnancy intervals (eg, &gt;10 years)&mdash;not by short interpregnancy intervals.</p><p><strong>(Choice E)</strong>&nbsp; A protracted labor course is more likely with advanced maternal age (age &gt;35), fetal macrosomia, and an increased interpregnancy interval (eg, &gt;24 months).&nbsp; Risk is not increased by a short interpregnancy interval.</p><p><strong>Educational objective:</strong><br>Short interpregnancy intervals (eg, &lt;6-18 months between delivery and next pregnancy) are associated with an increased risk of pregnancy complications including preterm labor, preterm prelabor rupture of membranes, and low birth weight.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23687,
            "topic": "Preterm premature rupture of the membranes",
            "titleId": 23687,
            "title": "Preterm premature rupture of the membranes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational diabetes mellitus",
                    "choiceNumber": 1,
                    "correctTaken": 732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postterm pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 3,
                    "correctTaken": 2200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm prelabor rupture of membranes",
                    "choiceNumber": 4,
                    "correctTaken": 11048,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Protracted labor course",
                    "choiceNumber": 5,
                    "correctTaken": 1925,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22990461",
                    "mediaDataId": 0,
                    "title": "Interpregnancy interval and obstetrical complications.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22990461",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 142,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16703,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 142,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 15857,
            "questionIndex": 17296,
            "questionText": "<p>A 33-year-old woman, gravida 3 para 2, at 37 weeks gestation is admitted in active labor.&nbsp; The patient&#39;s first child was born via cesarean delivery for breech presentation, and her second was born via spontaneous vaginal delivery.&nbsp; She receives epidural analgesia on admission and her contractions become nonpainful.&nbsp; An intrauterine pressure catheter is placed due to variable decelerations, which resolve with amnioinfusion.&nbsp; The patient reaches a cervical dilation of 10 cm and 100% effacement; the fetal vertex is at +1 station.&nbsp; After she pushes for 20 minutes, there is a sudden onset of abdominal pain, which is initially intermittent but becomes constant after a few minutes.&nbsp; The fetal heart rate tracing is shown in the following <a href=\"27871\">exhibit</a>.&nbsp; On repeat examination, the cervix is 10 cm dilated and 100% effaced, and the fetal vertex has retracted to &#8722;2 station.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"28624\" src=\"https://www.uworld.com/media/L54679.jpg\" ></p><p>This laboring patient with sudden-onset abdominal pain likely has <strong>uterine rupture</strong>, a full-thickness myometrial tear.&nbsp; Uterine rupture typically occurs in patients with <strong>prior uterine surgery</strong> (eg, prior cesarean delivery regardless of subsequent vaginal delivery) because inelastic uterine scar tissue can separate with contractions.</p><p>When the uterus ruptures, maternal and fetal compromise occurs by multiple mechanisms:</p><ul><li>If the placenta is involved, fetal perfusion is disrupted, leading to fetal hypoxia (ie, late decelerations, prolonged bradycardia).&nbsp; If the umbilical cord prolapses into the maternal abdomen, cord compression may increase (ie, variable decelerations).&nbsp; Because either or both are likely to occur, an abrupt <strong>fetal heart rate tracing abnormality</strong> is the most common finding of uterine rupture.</li><li>Disordered contractions occur because ruptured myometrial fibers cannot contract in unison.&nbsp; This is often evidenced by progressively decreasing contraction amplitude (ie, <a href=\"27872\">staircase sign</a> on tocodynamometry).</li><li>Partial fetal delivery into the maternal abdomen can cause fetal head retraction (eg, +1 to &#8722;2 station) and <strong>loss of fetal station</strong>.</li><li>Myometrial tearing causes severe abdominal pain and massive intraabdominal bleeding, which may result in hemodynamic instability.</li></ul><p>Uterine rupture is an obstetric emergency and requires emergency <strong>laparotomy and cesarean delivery</strong> for immediate delivery and uterine repair.</p><p><strong>(Choice A)</strong>&nbsp; Although amnioinfusion alleviates umbilical cord compression, it does not resolve prolonged fetal bradycardia caused by placental disruption.</p><p><strong>(Choice C)</strong>&nbsp; The McRoberts maneuver with suprapubic pressure facilitates delivery in patients with <a href=\"5890\">shoulder dystocia</a>.&nbsp; This condition can present with fetal head retraction against the perineum (ie, turtle sign); however, it does not cause sudden, severe abdominal pain.</p><p><strong>(Choice D)</strong>&nbsp; Vacuum-assisted vaginal delivery may be performed in patients who are 10 cm dilated and require immediate delivery (eg, nonreassuring fetal heart rate).&nbsp; In this patient, however, fetal head retraction to &#8722;2 station has made this procedure unsafe.&nbsp; In addition, vaginal delivery does not address this patient&#39;s uterine rupture, which requires laparotomy to repair.</p><p><strong>(Choice E)</strong>&nbsp; Oxytocin infusion increases contraction frequency and strength in patients with inadequate contractions.&nbsp; However, it is not administered in the setting of acute fetal bradycardia due to the risk of further fetal compromise.</p><p><strong>Educational objective:</strong><br>Patients with prior uterine surgery (eg, cesarean delivery) are at increased risk for uterine rupture, which can present with abdominal pain, fetal heart rate tracing abnormalities, progressively decreasing contraction amplitude, and loss of fetal station.&nbsp; Management is with emergency laparotomy and cesarean delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer amnioinfusion bolus",
                    "choiceNumber": 1,
                    "correctTaken": 20,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform laparotomy and cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 4529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform McRoberts maneuver with suprapubic pressure",
                    "choiceNumber": 3,
                    "correctTaken": 206,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform vacuum-assisted vaginal delivery",
                    "choiceNumber": 4,
                    "correctTaken": 240,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start an oxytocin infusion",
                    "choiceNumber": 5,
                    "correctTaken": 77,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17877673",
                    "mediaDataId": 0,
                    "title": "Risk factors for uterine rupture and neonatal consequences of uterine rupture: a population-based study of successive pregnancies in Sweden.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17877673",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681543",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 205: vaginal birth after cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681543",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 5072,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 89,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 125,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 15532,
            "questionIndex": 16964,
            "questionText": "<p>A 28-year-old woman, gravida 2 para 1, at 24 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She has had increasing shortness of breath but no cough or chest pain.&nbsp; The patient has had no vaginal bleeding, leakage of fluid, or contractions.&nbsp; Fetal movement is normal.&nbsp; She has no chronic medical conditions, and her only prior surgery is a cesarean delivery with her first pregnancy.&nbsp; The patient had a fetal anatomy ultrasound at 18 weeks gestation, but not all structures were well visualized.&nbsp; Blood pressure is 116/70 mm Hg and pulse is 68/min.&nbsp; Fundal height is 32 cm.&nbsp; Ultrasound reveals an amniotic fluid index of 40 cm (normal: 8-24 cm).&nbsp; The fetus is in breech presentation and has an estimated fetal size consistent with 24 weeks gestation.&nbsp; An isolated tracheoesophageal fistula is visualized.&nbsp; The placenta is located posteriorly.&nbsp; This patient is at increased risk for which of the following obstetric complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34535\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Amniotic fluid index</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Oligohydramnios (AFI &lt;5 cm)</strong></p></td><td><p align=\"center\"><strong>Polyhydramnios (AFI &ge;24 cm)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Preeclampsia</li><li>Abruptio placentae</li><li>Uteroplacental insufficiency</li><li>Renal anomalies</li><li>NSAIDs</li></ul></td><td><ul><li>Esophageal/duodenal atresia</li><li>Anencephaly</li><li>Multiple gestation</li><li>Congenital infection</li><li>Diabetes mellitus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Meconium aspiration</li><li>Preterm delivery</li><li>Umbilical cord compression</li></ul></td><td><ul><li>Fetal malpresentation</li><li>Umbilical cord prolapse</li><li>Preterm labor</li><li>Preterm prelabor rupture of membranes</li></ul></td></tr><tr><td colspan=\"3\"><p style=\"margin-left:.1in;\"><strong>AFI</strong> = amniotic fluid index;<strong> NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>Amniotic fluid volume is maintained via amniotic fluid production (ie, fetal urination) and removal (ie, fetal swallowing); a normal volume is required for fetal development (eg, lung maturity).&nbsp; This patient has <strong>polyhydramnios</strong>, an excessive <strong>amniotic fluid index (&#8805;24 cm)</strong>.&nbsp;&nbsp;&nbsp;In this case, polyhydramnios is due to an isolated fetal <a href=\"3339\">tracheoesophageal fistula</a> that impairs fetal swallowing and removal of amniotic fluid.&nbsp; Most patients with polyhydramnios are asymptomatic and have a <strong>uterine size-larger-than-dates discrepancy</strong> (eg, fundal height 32 cm at 24 weeks gestation); others may have dyspnea due to insufficient maternal lung expansion from an enlarged uterus.</p><p>Polyhydramnios, especially with increasing severity, can cause obstetric complications due to uterine overdistension and increased intraamniotic pressure.&nbsp; The increased tension of the fetal membranes makes them more susceptible to rupture, placing these patients at higher risk for <strong>preterm prelabor rupture of membranes</strong>.&nbsp; Uterine overdistension may also cause inflammation, prostaglandin release, uterine irritability, and an increased risk of <strong>preterm labor</strong>.&nbsp; Additional complications include fetal malpresentation (eg, breech), umbilical cord prolapse, and postpartum uterine atony.&nbsp; Patients with symptomatic polyhydramnios may benefit from amnioreduction (ie, amniotic fluid removal by <a href=\"6298\">amniocentesis</a>).</p><p><strong>(Choice A)</strong>&nbsp; The risk of placenta accreta is increased in patients with a prior cesarean delivery and an anterior placenta due to abnormal placental attachment at the uterine scar.&nbsp; This patient&#39;s placenta is posterior.</p><p><strong>(Choice B)</strong>&nbsp; The risk of postterm pregnancy is increased in nulligravid patients and those with a history of postterm delivery.&nbsp; Polyhydramnios increases the risk of preterm delivery.</p><p><strong>(Choice C)</strong>&nbsp; Preeclampsia is associated with oligohydramnios (ie, a uterine size-less-than-dates discrepancy) due to uteroplacental insufficiency, fetal growth restriction, and decreased fetal urine output.&nbsp; This patient has polyhydramnios.</p><p><strong>(Choice E)</strong>&nbsp; The risk of shoulder dystocia is increased in fetuses with macrosomia, another common cause of a uterine size-greater-than-dates discrepancy.&nbsp; This patient&#39;s estimated fetal size on ultrasound is equal to the gestational age indicating normal growth, not macrosomia.</p><p><strong>Educational objective:</strong><br>Polyhydramnios, or excessive amniotic fluid index (&#8805;24 cm), can occur due to impaired fetal swallowing (eg, tracheoesophageal fistula).&nbsp; Patients with polyhydramnios are at higher risk of obstetric complications (eg, preterm prelabor rupture of membranes) due to uterine overdistension and increased intraamniotic pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11178,
            "topic": "Polyhydramnios",
            "titleId": 11178,
            "title": "Polyhydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Placenta accreta",
                    "choiceNumber": 1,
                    "correctTaken": 302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postterm pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 3,
                    "correctTaken": 92,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm prelabor rupture of membranes",
                    "choiceNumber": 4,
                    "correctTaken": 4190,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Shoulder dystocia",
                    "choiceNumber": 5,
                    "correctTaken": 219,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "713",
                    "mediaDataId": 0,
                    "title": "Amniotic fluid: an overview",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24771905",
                    "mediaDataId": 0,
                    "title": "Polyhydramnios: causes, diagnosis and therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24771905",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26284599",
                    "mediaDataId": 0,
                    "title": "Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26284599",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26948899",
                    "mediaDataId": 0,
                    "title": "Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26948899",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 5003,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 94,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 18236,
            "questionIndex": 19703,
            "questionText": "<p>A 26-year-old primigravida at 12 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She reports no concerns with her pregnancy but for the past month the patient has had episodes of dyspnea and wheezing twice a week.&nbsp; She has a 10-year history of asthma that had previously been well-controlled with a low-dose inhaled corticosteroid and an as-needed albuterol inhaler.&nbsp; She has no other medical conditions and takes a daily prenatal vitamin.&nbsp; Vital signs and pulse oximetry are normal.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient has gained 4 kg (8.8 lb) during this pregnancy.&nbsp; Lung auscultation reveals normal breath sounds.&nbsp; The remainder of the physical examination shows no abnormalities.&nbsp; Which of the following is the most appropriate response by the physician?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T62014\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Recognizing medication nonadherence</strong></p></td></tr><tr><td><p align=\"center\"><strong>Suggestive features</strong></p></td><td><ul><li>Unexpected loss of disease control</li><li>Poor understanding of drug indication &amp; schedule</li><li>Frequent reports of adverse drug effects</li></ul></td></tr><tr><td><p align=\"center\"><strong>Possible interventions</strong></p></td><td><ul><li>Review schedule &amp; dosing instructions</li><li>Educate patient on purpose &amp; how to take medication</li><li>Reduce/consolidate medication list</li><li>Increase frequency of follow-up</li></ul></td></tr></tbody></table></div><p>In <strong>pregnancy</strong>, worsening asthma can be due to several factors (eg, altered daily activities, increased stress/anxiety), including (in a third of cases) pregnancy itself.&nbsp; In addition, pregnant patients may discontinue medications due to limited knowledge regarding their safety and concerns about fetal harm.&nbsp; Although nonessential medications should be minimized in pregnancy, most <strong>asthma</strong> medications (including inhaled beta agonists and inhaled corticosteroids) are safe, and their discontinuation may lead to worsening asthma symptoms, which are associated with worse outcomes.</p><p>Given this patient&#39;s pattern of worsening symptoms <strong>after years of good control</strong>, medication <strong>discontinuation</strong> (eg, out of fear of harming the fetus) should be considered.&nbsp; The discussion should begin with a <strong>nonjudgmental inquiry</strong> into the patient&#39;s <strong>use </strong>of her asthma medications.&nbsp; The review should focus on when, how, and how often the patient uses both the controller and rescue medication.&nbsp; In many cases, providing reassurance regarding the <strong>safety</strong> of most <strong>asthma medications </strong>and education regarding the benefits of good asthma control during pregnancy is helpful.&nbsp; Careful follow-up (eg, more frequent visits) has been found to improve adherence to asthma medications.</p><p><strong>(Choice A)</strong>&nbsp; Excessive maternal weight gain in pregnancy is associated with increased risk for exacerbation of asthma.&nbsp; However, attributing this patient&#39;s worsening asthma to weight and counseling about diet is premature when her medication adherence is unknown.</p><p><strong>(Choice B)</strong>&nbsp; Using judgmental language or scare tactics and starting with closed ended questions about medication adherence is not conducive to a productive discussion and may erode trust in the provider&#39;s care.</p><p><strong>(Choice C)</strong>&nbsp; Although asthma can worsen due to pregnancy itself, this patient&#39;s symptoms should not be attributed simply to pregnancy without an appropriate review of medication use.&nbsp; If medication discontinuation is identified as the cause of her worsening symptoms, it may be possible to gain better control by restarting these medications.&nbsp; Furthermore, even if the worsening asthma is due to pregnancy, medication adjustment (rather than close monitoring of symptoms) may be required.</p><p><strong>Educational objective:</strong><br>Most asthma medications are safe in pregnancy and should be continued.&nbsp; Worsening symptoms after years of good control suggests nonadherence to controller medication.&nbsp; When nonadherence is considered, the discussion should begin with a nonjudgmental inquiry into the patient&#39;s use of medication, focusing on when, how, and how often the patient uses both the controller and rescue medication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4795,
            "topic": "Asthma",
            "titleId": 4795,
            "title": "Asthma",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s possible that your weight could be worsening your asthma symptoms; let&#39;s talk about ways to promote healthy eating during pregnancy.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 1072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Poorly controlled asthma can have serious consequences for the baby; have you been taking your medications regularly?&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 404,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Sometimes asthma gets worse early in pregnancy and then improves later on; we&#39;ll continue your medications and closely monitor your symptoms.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 6507,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your asthma symptoms seem to be getting worse; let&#39;s review how often you&#39;ve been taking your inhalers.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 8840,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 142,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16823,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 142,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 3116,
            "questionIndex": 3116,
            "questionText": "<p>A 23-year-old primigravida at 38 weeks gestation comes to labor and delivery for spontaneous rupture of membranes and painful contractions.&nbsp; The patient has had an uncomplicated prenatal course and a negative group B <em>Streptococcus</em> culture last week.&nbsp; Leopold maneuvers show an estimated fetal weight of 3.6 kg (8 lb).&nbsp; Cervical examination shows the cervix to be 8 cm dilated and 90% effaced with the fetal vertex at 0 station.&nbsp; The patient is admitted and epidural analgesia is administered.&nbsp; She reports increasing rectal pressure; repeat cervical examination is unchanged.&nbsp; An intrauterine pressure catheter is placed and shows contractions every 2-3 minutes, and the sum of contraction strength is 240 Montevideo units over 10 minutes.&nbsp; This contraction pattern continues, and 4 hours later the cervix remains unchanged.&nbsp; Fetal heart rate tracing is category 1.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36419\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Disorders of the active phase of labor</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width: 50%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width: 25%;\"><p align=\"center\"><strong>Treatment</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Protraction</strong></p></td><td style=\"width: 50%;\"><ul><li>Cervical change slower than expected</li><li>&plusmn; Inadequate contractions</li></ul></td><td style=\"width: 25%;\"><p style=\"text-align: center;\">Oxytocin</p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Arrest</strong></p></td><td style=\"width: 50%;\"><ul><li>No cervical change for &ge;4 hours with adequate contractions<br />OR</li><li>No cervical change for &ge;6 hours with inadequate contractions</li></ul></td><td style=\"width: 25%;\"><p style=\"text-align: center;\">Cesarean delivery</p></td></tr></tbody></table></div><p>The first stage of labor begins with the onset of regular contractions and ends when the cervix is 10 cm dilated.&nbsp; It consists of a latent phase involving gradual cervical dilation and an active phase with rapid dilation.&nbsp; The transition between the latent and active phase occurs at 6 cm dilation.</p><p>The active phase of labor (6-10 cm cervical dilation) has an expected, predictable rate of cervical dilation of &#8805;1 cm every 2 hours.&nbsp; This patient has <strong>active phase arrest</strong>, defined as <strong>no cervical change for &#8805;4 hours</strong> despite <strong>adequate contractions</strong> (<a href=\"22112\">&#8805;200 Montevideo units</a> in a 10-minute interval) or no cervical change for &#8805;6 hours with inadequate contractions.&nbsp; Causes include uterine (eg, inadequate contractions), fetal (eg, malposition, macrosomia), or pelvic (eg, deformity or fracture) etiologies.</p><p>The best next step in management of active phase arrest is <strong>cesarean delivery</strong> because no further cervical dilation is expected and delaying delivery increases maternal-fetal morbidity (eg, intraamniotic infection, postpartum hemorrhage) <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Amnioinfusion is performed using an intrauterine pressure catheter and is indicated for fetal heart rate tracing abnormalities (ie, variable decelerations).&nbsp; It is not used for labor augmentation because it does not affect cervical dilation.</p><p><strong>(Choice C)</strong>&nbsp; Oxytocin augments labor by increasing contraction frequency and strength.&nbsp; Oxytocin is used for patients who meet criteria for labor protraction (ie, cervical dilation rate &lt;1 cm/2 hr) but not for those who meet criteria for labor arrest.</p><p><strong>(Choice D)</strong>&nbsp; An operative vaginal delivery (eg, vacuum-assisted vaginal delivery) is performed during the second stage of labor (10 cm dilation until fetal delivery) to expedite delivery for category III tracings or maternal exhaustion.&nbsp; This patient is 8 cm dilated.</p><p><strong>Educational objective:</strong><br>Active phase arrest occurs at a cervical dilation of &#8805;6 cm and is defined as no cervical change for &#8805;4 hours with adequate contractions or &#8805;6 hours with inadequate contractions.&nbsp; Active phase arrest is managed by cesarean delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23791,
            "topic": "Labor management",
            "titleId": 23791,
            "title": "Labor management",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 8098,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous oxytocin",
                    "choiceNumber": 3,
                    "correctTaken": 4404,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Operative vaginal delivery",
                    "choiceNumber": 4,
                    "correctTaken": 1477,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat cervical examination in 2 hours",
                    "choiceNumber": 5,
                    "correctTaken": 2586,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21099592",
                    "mediaDataId": 0,
                    "title": "Contemporary patterns of spontaneous labor with normal neonatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21099592",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23090537",
                    "mediaDataId": 0,
                    "title": "Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23090537",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 70,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16684,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 70,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 13335,
            "questionIndex": 14709,
            "questionText": "<p>A 36-year-old woman, gravida 1 para 0, comes to the office for an initial prenatal visit.&nbsp; The patient recently immigrated to the United States and has not received prenatal care.&nbsp; She is at 22 weeks gestation by a sure, regular last menstrual period.&nbsp; Vital signs are normal.&nbsp; Height is 152.5 cm (5 ft 0 in). BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fundal height is 27 cm.&nbsp; Routine prenatal laboratory results include:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"width:360.85pt;\">Complete blood count</td></tr><tr><td style=\"width:175pt;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"width:175.05pt;\">9.6 g/dL</td></tr><tr><td style=\"width:175pt;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"width:175.05pt;\">200,000/mm3</td></tr><tr><td style=\"width:175pt;\">Hepatitis B surface antigen (HBsAg)</td><td style=\"width:175.05pt;\">negative</td></tr><tr><td style=\"width:175pt;\">HIV-1 antibody</td><td style=\"width:175.05pt;\">negative</td></tr><tr><td style=\"width:175pt;\">Rapid plasma reagin (RPR)</td><td style=\"width:175.05pt;\">not detected</td></tr></tbody></table><p>Ultrasound reveals a male fetus with an edematous scalp and nuchal fold.&nbsp; The fetal abdomen contains a large amount of echolucent fluid.&nbsp; The biparietal diameter and femur length measure at 22 weeks gestation.&nbsp; The single deepest pocket of amniotic fluid is 12 cm, and the placenta is thickened to 6 cm.&nbsp; Fetal heart rate is 170/min.&nbsp; Which of the following is the most likely cause of this fetal presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32512\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Alpha thalassemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Genotype</strong></p></td><td><p align=\"center\"><strong>Disorder</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\">1 gene loss<br />(&alpha;&alpha;/&alpha;&minus;)</p></td><td><p align=\"center\">Alpha thalassemia minima</p></td><td><p align=\"center\">Asymptomatic, silent carrier</p></td></tr><tr><td><p align=\"center\">2 gene loss<br />(&alpha;&alpha;/&minus;&minus;) or (&alpha;&minus;/&alpha;&minus;)</p></td><td><p align=\"center\">Alpha thalassemia minor</p></td><td><p align=\"center\">Mild microcytic anemia</p></td></tr><tr><td><p align=\"center\">3 gene loss<br />(&alpha;&minus;/&minus;&minus;)</p></td><td><p align=\"center\">Hemoglobin H disease</p></td><td><p align=\"center\">Chronic hemolytic anemia</p></td></tr><tr><td><p align=\"center\">4 gene loss<br />(&minus;&minus;/&minus;&minus;)</p></td><td><p align=\"center\">Alpha thalassemia major,<br />hemoglobin Barts disease</p></td><td><p align=\"center\">Hydrops fetalis: anasarca,<br />high-output cardiac failure,<br />death in utero</p></td></tr></tbody></table></div><p>This fetus has ascites (eg, echolucent abdominal fluid), skin edema, polyhydramnios (single deepest pocket &#8805;8 cm), and placental thickening (reflecting intravillous edema) consistent with <strong>hydrops fetalis</strong> (<a href=\"23610\">fetal hydrops</a>); additional features may include pleural and pericardial effusion.&nbsp; Hydrops fetalis can occur due to a variety of disorders (eg, Rh alloimmunization, parvovirus B19).&nbsp; In this fetus with hydrops fetalis and no associated dysmorphic features (eg, normal biparietal diameter and femur length), the most likely cause is <strong>alpha-thalassemia major</strong>.</p><p><a href=\"3242\">Normal hemoglobin</a> is a heterotetramer composed of 2 alpha and 2 beta chains (hemoglobin A) in adults, or 2 alpha and 2 gamma chains (hemoglobin F) in fetuses.&nbsp; Patients with alpha-thalassemia have reduced or absent alpha chain synthesis, and the disease severity is determined by the number of affected genes.&nbsp; Most patients have alpha-thalassemia minor with mild anemia (as in this mother).&nbsp; However, when both parents have the &#x22;cis&#x22; (&#945;&#945;/- -) genotype of alpha-thalassemia minor, their fetus can inherit a <strong>loss of all 4 alpha-globin genes</strong> (- -/- -), leading to <strong>no alpha-globin chain production</strong>.</p><p>Without alpha chains, fetuses form gamma homotetramers (4 gamma chains) known as <strong>hemoglobin Barts</strong>, which has an extreme affinity for oxygen (&gt;10 times more than hemoglobin A) and does not release oxygen to the tissues.&nbsp; This results in <strong>severe fetal hypoxemia</strong>, development of high-output cardiac failure, and subsequent hydrops fetalis and <strong>intrauterine fetal demise</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Achondroplasia can present with hydrops fetalis, but affected fetuses typically have macrocephaly and shortened long bones on prenatal ultrasound.&nbsp; This fetus&#39;s biparietal diameter and femur length are normal.</p><p><strong>(Choice C)</strong>&nbsp; Beckwith-Wiedemann syndrome is associated with polyhydramnios; however, affected fetuses typically have macrosomia and omphalocele (not seen in this fetus).</p><p><strong>(Choice D)</strong>&nbsp; Cystic fibrosis may be associated with hyperechogenic bowel or absent gallbladder on prenatal ultrasound but not hydrops fetalis.</p><p><strong>(Choice E)</strong>&nbsp; Turner syndrome (45, X) can present with nuchal thickening, <a href=\"15361\">cystic hygroma</a> (fluid-filled lymphatic sac), and hydrops fetalis.&nbsp; This diagnosis is unlikely because Turner syndrome only affects females.</p><p><strong>Educational objective:</strong><br>Alpha-thalassemia major is an inherited disorder of absent alpha-globin chain production necessary to form hemoglobin F.&nbsp; Fetuses with alpha-thalassemia major produce hemoglobin Barts (4 gamma chains), which does not release oxygen to the tissues.&nbsp; This results in severe fetal hypoxemia, high-output heart failure, hydrops fetalis (eg, skin edema, ascites), and subsequent fetal demise.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14178,
            "topic": "Fetal hydrops",
            "titleId": 14178,
            "title": "Fetal hydrops",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Achondroplasia",
                    "choiceNumber": 1,
                    "correctTaken": 1089,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alpha-thalassemia major",
                    "choiceNumber": 2,
                    "correctTaken": 7751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beckwith-Wiedemann syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 5470,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cystic fibrosis",
                    "choiceNumber": 4,
                    "correctTaken": 1266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Turner syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 1112,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20507641",
                    "mediaDataId": 0,
                    "title": "Alpha-thalassemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20507641",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30550718",
                    "mediaDataId": 0,
                    "title": "Atypical prenatal ultrasound presentation and neuropathological findings in a neonate with alpha thalassemia major: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30550718",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25712632",
                    "mediaDataId": 0,
                    "title": "Etiology of nonimmune hydrops fetalis: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25712632",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 86,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 16688,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 79,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}